Cytoskeletal Remodeling in E-cadherin Mutant Cells: From Architecture to Invasion

Abstract

This article synthesizes current research on how E-cadherin dysfunction, a hallmark of epithelial cancers and hereditary diffuse gastric cancer (HDGC), triggers profound reorganization of the cytoskeleton. We explore the foundational biology linking E-cadherin to microtubule and actin networks, detail innovative computational pipelines for quantifying cytoskeletal architecture, and address methodological challenges in modeling and analysis. By comparing phenotypes across different E-cadherin mutation types and cellular contexts, we provide a validated framework for understanding how cytoskeletal alterations drive invasive behavior. This resource is tailored for researchers and drug development professionals aiming to target cytoskeletal remodeling for cancer diagnosis and therapeutic intervention.

E-cadherin and the Cytoskeleton: Deciphering the Biological Link in Cell Adhesion and Architecture

The E-cadherin-catenin complex is a master regulator of epithelial integrity, functioning not only as a structural component of cell-cell adhesions but also as a critical signaling hub. This complex orchestrates cellular architecture by dynamically interacting with the actin cytoskeleton and microtubule network. Disruption of these interactions, through genetic mutations or aberrant signaling, is a hallmark of epithelial-to-mesenchymal transition (EMT), fibrosis, and cancer metastasis. This guide compares the molecular functions of the wild-type E-cadherin-catenin complex against dysfunctional mutants, providing a synthesis of key experimental data and methodologies that underscore its role as a central mediator of cytoskeletal architecture and cellular phenotype.

Classical cadherins are calcium-dependent cell-cell adhesion molecules essential for tissue formation, integrity, and function [1] [2]. Among them, E-cadherin is predominantly expressed in epithelia and constitutes the core of adherens junctions. The E-cadherin-catenin complex is comprised of the transmembrane E-cadherin protein, which binds intracellularly to a group of proteins collectively known as catenins: p120-catenin, β-catenin (or its close relative plakoglobin), and α-catenin [1] [3]. This complex is traditionally viewed as a physical bridge connecting the extracellular environment to the intracellular cytoskeletal networks, primarily the actin cytoskeleton, and more recently, the microtubule network [2].

The prevailing model suggests that the cytoplasmic domain of E-cadherin binds directly to β-catenin or plakoglobin, which in turn associates with α-catenin. α-Catenin has been proposed to function as the primary link to the actin cytoskeleton, either through direct actin binding or through interactions with various actin-associated proteins such as vinculin, α-actinin, and formins [4] [5]. However, recent biochemical and cell biological evidence challenges the simplicity of this stable linkage model, suggesting a more dynamic and regulated interaction [4] [5]. Simultaneously, the complex interacts with the microtubule network, which facilitates its delivery to the plasma membrane and regulates its turnover [2] [3]. This guide provides a comparative analysis of the wild-type versus mutant E-cadherin-catenin complexes, detailing their distinct interactions with cytoskeletal components and the consequent physiological and pathological outcomes.

Structural and functional comparison: Wild-type vs. mutant complexes

Core composition and cytoskeletal linkages

Table 1: Core Components of the E-cadherin-Catenin Complex and Their Primary Functions

Component	Primary Binding Partners	Function in Wild-Type Complex	Consequence of Dysfunction
E-cadherin	β-catenin, p120-catenin	Ca²⁺-dependent homophilic adhesion; nucleates complex assembly [1]	Loss of cell-cell adhesion; increased invasion and metastasis [1] [6]
β-catenin	E-cadherin, α-catenin	Links E-cadherin to α-catenin; key Wnt signaling transducer [1] [7]	Cytoplasmic/nuclear accumulation; constitutive Wnt signaling; tumorigenesis [1]
α-catenin	β-catenin, Actin, Vinculin	Regulates actin linkage; cannot bind β-catenin and actin simultaneously [4] [5]	Disrupted adhesion strength; increased cell migration and proliferation [5]
p120-catenin	Juxtamembrane domain of E-cadherin	Stabilizes E-cadherin at membrane; regulates Rho GTPases [2]	Increased E-cadherin endocytosis; altered Rho/Rac signaling [2]

The interaction between the E-cadherin cytoplasmic domain and β-catenin is a cornerstone of the complex's stability. Structural studies show this interaction spans all 12 armadillo repeats of β-catenin, and phosphorylation of the E-cadherin cytoplasmic domain can enhance this binding [7]. A pivotal, yet controversial, aspect is the connection to actin. Direct binding experiments with purified proteins have demonstrated that α-catenin binding to the E-cadherin-β-catenin complex and its binding to F-actin are mutually exclusive [4] [5]. This allosteric regulation is influenced by α-catenin's oligomeric state, with monomers favoring β-catenin binding and homodimers favoring actin binding [5].

Signaling output and disease correlates

Table 2: Signaling and Phenotypic Consequences of Wild-Type vs. Dysfunctional Complex

Parameter	Wild-Type Complex	Dysfunctional/Mutant Complex	Experimental Evidence
Cell-Cell Adhesion	Strong, stable adhesion [1]	Weak, unstable adhesion [1] [8]	Aggregation assays; measurement of transepithelial resistance [9]
β-Catenin Localization	Membrane-bound at junctions [1]	Cytoplasmic/Nuclear accumulation [1]	Immunofluorescence; subcellular fractionation [1]
Wnt Signaling Activity	Regulated (off without signal) [1]	Constitutively active [1]	TCF/LEF reporter assays [1]
EMT Markers	E-cadherin, ZO-1 expressed [1]	Vimentin, α-SMA, FSP1 expressed [1]	Western blot; immunocytochemistry [1]
Extrusion Phenotype	Integrated in monolayer [8]	Basal extrusion into ECM [8]	3D culture models; phase-field modeling [8]
Invasion/Metastasis	Low potential [1] [6]	High potential [1] [8] [6]	In vitro invasion assays; in vivo metastasis models [1]

The complex's dysfunction is a primary trigger for Epithelial-Mesenchymal Transition (EMT), a process critical in development, fibrosis, and cancer [1]. During EMT, cells lose E-cadherin expression, dissolve junctions, and gain a migratory, invasive mesenchymal phenotype. The loss of E-cadherin frees β-catenin from the membrane, allowing its nuclear translocation and activation of pro-EMT and oncogenic genes like c-myc and cyclin D1 [1]. In fibrotic disorders of the kidney, lung, and liver, decreased E-cadherin and nuclear β-catenin are consistently observed, linking the complex's disruption to excessive extracellular matrix deposition [1]. In cancer, particularly invasive lobular carcinoma and metaplastic breast cancers, E-cadherin loss or β-catenin stabilization mutations are common, correlating with poor prognosis [1].

Experimental protocols for analyzing cytoskeletal linkages

Biochemical reconstitution and actin pelleting assays

A foundational protocol for directly testing the physical linkage between the cadherin-catenin complex and actin involves in vitro reconstitution with purified proteins.

• Protein Purification: Recombinant E-cadherin cytoplasmic domain (Ecyto), β-catenin, and α-catenin are expressed and purified from bacterial or mammalian systems [4].
• Complex Formation: Ecyto, β-catenin, and α-catenin are mixed in equimolar ratios to form the ternary complex [4] [5].
• Actin Cosedimentation: F-actin is polymerized from purified G-actin. The pre-formed cadherin-catenin complex is incubated with F-actin in a physiological buffer. The mixture is then subjected to ultracentrifugation at high speed (e.g., 100,000-150,000 × g), which pellets F-actin and any bound proteins [4] [5].
• Analysis: The supernatant (unbound) and pellet (bound) fractions are analyzed by SDS-PAGE and Coomassie staining or immunoblotting.
• Key Finding: In such assays, α-catenin alone pellets with F-actin, but the ternary Ecyto-β-catenin-α-catenin complex remains in the supernatant, demonstrating the lack of a stable, direct linkage [4] [5]. This mutually exclusive binding persists even when the complex is oligomerized to mimic junctional clustering [4].

Ventral membrane patch reconstitution assay

To test interactions in a more native membrane environment, a ventral membrane patch assay was developed.

• Cell Plating and Unroofing: Epithelial cells (e.g., MDCK) are plated on a substratum coated with the purified extracellular domain of E-cadherin. After cells spread, they are briefly sonicated. This "unroofing" procedure removes the dorsal membrane and cytoplasmic contents, leaving behind ventral membrane patches attached to the cadherin substratum [4].
• Depletion and Reconstitution: Membrane-associated proteins are stripped from these patches using a chaotrope like guanidine hydrochloride. The stripped patches, which retain transmembrane E-cadherin, are then incubated with purified recombinant catenins (β-catenin, α-catenin) and/or cytoplasmic extracts [4].
• Visualization: The reconstituted complexes are visualized by immunofluorescence staining to assess colocalization. Actin binding can be tested by adding F-actin to the reconstitution mixture.
• Key Finding: Even in this more native context, the E-cadherin-β-catenin-α-catenin complex reconstituted on membranes did not bind stably to F-actin, reinforcing the model of a dynamic, rather than static, linkage [4].

Analyzing mutant-driven basal extrusion in vitro

To model early invasion events in Hereditary Diffuse Gastric Cancer (HDGC), an extrusion assay using E-cadherin mutant cells is employed.

• Cell Engineering: Cancer cell lines (e.g., HCT116) are engineered to express HDGC-associated E-cadherin mutants (e.g., A634V, R749W, V832M) affecting different protein domains [8].
• Co-culture Setup: A small number of fluorescently labeled mutant cells are mixed with a majority of wild-type cells and cultured on a collagen matrix, creating a mosaic monolayer [8].
• Imaging and Quantification: Confocal z-stack imaging is used to capture the 3D structure of the monolayer. The position of each mutant cell nucleus relative to the monolayer plane is determined.
• Quantification: The percentage of mutant cells that have extruded basally (into the collagen) versus apically (into the lumen) is calculated and compared to wild-type controls [8].
• Key Finding: E-cadherin mutant cells, particularly those with juxtamembrane (R749W) or intracellular (V832M) mutations, exhibit significantly higher rates of basal extrusion compared to wild-type cells, providing a direct experimental model for the initial steps of invasion [8].

Visualization of complex dynamics and signaling

The scientist's toolkit: Essential research reagents

Table 3: Key Reagents for Studying the E-cadherin-Catenin Complex

Reagent / Tool	Type	Primary Function in Research	Example Use Case
DECMA-1 Antibody	Monoclonal Antibody	Binds E-cadherin ectodomain; can block adhesion or detect soluble E-cadherin [10]	Investigating the role of soluble E-cadherin in spheroidogenesis and as a biomarker [10]
Recombinant E-cadherin/Fc Chimera	Protein (Extracellular Domain)	Coating substrata to promote specific cadherin-mediated cell adhesion and signaling [4]	Creating a defined system for ventral membrane patch preparation and adhesion studies [4]
β/α-Catenin Chimera	Recombinant Fusion Protein	Covalently links β-catenin's α-binding site to α-catenin; ensures complex formation for binding studies [4] [5]	Testing the mutual exclusivity of α-catenin binding to β-catenin vs. F-actin in pelleting assays [4]
HDGC-associated E-cadherin Mutants	Genetically Engineered Cell Lines	Express pathogenic variants (e.g., A634V, R749W, V832M) to model disease mechanisms [8]	Studying basal extrusion and early invasion in mosaic epithelial monolayers [8]
Pak1 Inhibitors	Small Molecule Inhibitor	Inhibits Pak1 kinase activity, a regulator of actin/microtubule dynamics downstream of Rac [3]	Probing the role of Pak1 in WAVE2 complex translocation and lamellipodia formation [3]
c-Fms-IN-10	c-Fms-IN-10, MF:C22H19N7OS, MW:429.5 g/mol	Chemical Reagent	Bench Chemicals
Angoline hydrochloride	Angoline hydrochloride, MF:C22H22ClNO5, MW:415.9 g/mol	Chemical Reagent	Bench Chemicals

The E-cadherin-catenin complex functions not as a simple, static tether but as a highly dynamic and regulated interface that integrates extracellular adhesion with the intracellular cytoskeletal landscape. The wild-type complex maintains tissue integrity through a dynamic, allosterically controlled interaction with actin and coordinated support from the microtubule network. In contrast, mutant or dysfunctional complexes, as seen in HDGC and other cancers, result in a fundamental rewiring of cellular architecture. This leads to a loss of adhesive strength, misregulation of β-catenin signaling, and a shift towards a pro-invasive phenotype characterized by basal extrusion and metastasis. A comprehensive understanding of these mechanisms, facilitated by the experimental approaches and tools detailed in this guide, continues to provide critical insights for developing novel therapeutic strategies aimed at combating fibrosis and cancer metastasis.

E-cadherin, a calcium-dependent cell-cell adhesion protein encoded by the CDH1 gene, serves as a critical tumor suppressor and master regulator of epithelial tissue architecture. It forms homophilic interactions between adjacent cells and connects intracellularly to the cytoskeletal network, creating a mechanical link that maintains tissue integrity [11]. The loss of E-cadherin function represents a hallmark of the epithelial-mesenchymal transition (EMT) and is a well-established initiating event in invasive carcinomas, including diffuse gastric cancer and lobular breast cancer [11] [12]. This article provides a comprehensive comparison of cellular phenotypes between wild-type and E-cadherin-deficient cells, analyzing how disrupted adhesion propagates instability throughout the cytoskeletal network. We synthesize recent experimental evidence to guide research and therapeutic development in cancer biology.

Comparative Analysis: Wild-Type vs. E-cadherin-Deficient Cellular Phenotypes

The functional consequences of E-cadherin loss manifest across multiple cellular compartments and processes. The table below summarizes key phenotypic differences established through recent studies.

Table 1: Phenotypic Consequences of E-cadherin Loss

Cellular Feature	Wild-Type E-cadherin Phenotype	E-cadherin-Deficient/Mutant Phenotype	Experimental Evidence
Cell-Cell Adhesion	Stable adherens junctions; strong homophilic adhesion [11]	Weakened/impaired cell-cell contacts; immature junction formation [11] [12]	Engineered MCF10A CDH1-/- cells; Afadin mutant breast cancer cells [11] [12]
Cytoskeletal Organization	Radial apical microtubule network; normal F-actin distribution [11] [13]	Disrupted radial microtubule pattern; thicker, more numerous basal stress fibers [11] [13]	Whole genome RNAseq; novel computational pipeline on α-tubulin/TIRF images [11] [13]
Cell-ECM Adhesion	Normal cell-substrate adhesion [11]	Quantitative Data: Weaker cell-substrate adhesion; significant downregulation of ITGA1, COL8A1, COL4A2, COL12A1 [11]	RNAseq data from MCF10A CDH1-/- cells [11]
Migration Capacity	Standard, contact-inhibited migration [11]	Quantitative Data: Delayed migration in MCF10A CDH1-/- [11]; Increased invasive potential in other models [13] [8]	xCELLigence platform (Roche) and IncuCyte migration monitoring [11]
3D Extrusion & Invasion	Integrated within epithelium; rare basal extrusion [8]	Quantitative Data: Basal extrusion efficiency increases with ECM attachment; R749W mutant: 44.91% basal extrusion vs. WT [8]	Phase-field modelling; confocal xz-sections of monolayers on collagen [8]
Signaling Pathways	Balanced ERK signaling; regulated proliferation [14]	Quantitative Data: Activated EGFR-MEK/ERK signaling; HR for low E-cad/high pERK: 2.30 for EFS, 2.76 for DSS [14]	IHC on cervical cancer TMA; siRNA silencing in cell lines [14]

Detailed Experimental Methodologies

Generating an E-cadherin Knockout Model

To investigate the specific role of E-cadherin loss, researchers have employed isogenic cell lines. The non-tumorigenic breast cell line MCF10A and its engineered counterpart, MCF10A CDH1-/-, are widely used [11].

• Protocol:
  • Gene Editing: The CompoZr ZFN technology was used to create a homozygous 4 bp deletion in exon 11 of the CDH1 gene in MCF10A cells [11].
  • Cell Culture: Both isogenic lines are cultured in DMEM/F12 medium supplemented with 5% horse serum, 10 μg/ml insulin, 20 ng/ml EGF, 100 ng/ml cholera toxin, and 500 ng/ml hydrocortisone at 37°C with 5% COâ‚‚ [11].
  • Validation: Successful knockout is confirmed via Western blot and immunofluorescence using anti-E-cadherin antibodies (e.g., Santa Cruz, SC7870), showing absence of E-cadherin protein in the CDH1-/- line [11].

Computational Dissection of Cytoskeletal Architecture

A novel bioimaging pipeline enables quantitative analysis of cytoskeletal remodeling with high precision [13].

• Protocol:
  • Sample Preparation and Imaging: Cells are stained for α-tubulin and nuclei. Multiple images are acquired along the Z-axis for each channel [13].
  • Image Processing: Z-stacks are projected into 2D using maximum intensity projection (MIP). Deconvolution removes noise and blur, improving contrast and resolution [13].
  • Fiber Segmentation and Feature Extraction: A Gaussian filter smoothens the signal, followed by a Sato filter to highlight curvilinear structures. A Hessian filter generates binary images, which are then skeletonized. The pipeline automatically extracts key cytoskeletal features, including:
    • Line Segment Features (LSFs): Fiber orientation, length, and morphology.
    • Cytoskeleton Network Features (CNFs): Connectivity, complexity, and radiality relative to the nucleus centroid [13].

Quantifying Basal Extrusion in a Monolayer Model

The directionality of cell delamination is a critical step in early invasion [8].

• Protocol:
  • Model Setup: Cells expressing E-cadherin missense mutants (e.g., A634V, R749W, V832M) are labeled with a fluorescent dye and mixed with wild-type cells at highly diluted ratios [8].
  • 3D Culture: The cell mixture is cultured on top of a collagen matrix to form a monolayer where a single mutant cell is surrounded by wild-type neighbors [8].
  • Imaging and Quantification: Confocal xz-sections are used to determine the position of each cell's nucleus relative to the epithelial plane. The percentage of mutant cells that have extruded basally into the collagen matrix is calculated [8].

Molecular Mechanisms and Signaling Pathways

The transition from weakened adhesion to cytoskeletal instability is driven by several interconnected molecular pathways.

The Cadherin-Catenin-Actin Link and Afadin

The core adherens junction complex, comprising E-cadherin, p120-catenin, β-catenin, and αE-catenin, provides a physical bridge to the actin cytoskeleton. Loss of E-cadherin disrupts this link, leading to aberrant F-actin organization [12]. Recent research highlights the critical role of the scaffolding protein Afadin (AFDN), which stabilizes and matures the mechanical E-cadherin to F-actin connection. Somatic inactivation of Afadin in E-cadherin-expressing breast cancer cells results in immature adherens junctions, a noncohesive phenotype, and Actomyosin-dependent anoikis resistance, ultimately promoting single-cell invasion and metastasis [12].

ECM Attachment and Tissue Architecture

E-cadherin loss alone is often insufficient to induce full EMT or enhance transforming potential [11]. The invasive capacity is significantly modulated by the extracellular matrix (ECM) and tissue geometry. Phase-field modeling demonstrates that increased attachment to the ECM fibers, a trait of E-cadherin dysfunctional cells, dramatically raises basal extrusion efficiency [8]. Furthermore, vertex model simulations reveal that the cylindrical structure of gastric glands strongly promotes the invasive ability of E-cadherin-deficient cells, explaining the early and multifocal invasion patterns seen in hereditary diffuse gastric cancer (HDGC) [8].

ERK Signaling Activation

Beyond structural roles, E-cadherin loss activates pro-tumorigenic signaling pathways. In cervical cancer, E-cadherin silencing enhances EGFR-MEK/ERK signaling, promoting cancer cell proliferation. This creates a feed-forward loop where the loss of adhesion directly stimulates pathways that drive progression [14].

The diagram below integrates these mechanisms into a unified pathway from E-cadherin loss to cytoskeletal instability and invasion.

Diagram Title: Molecular Pathways from E-cadherin Loss to Instability

The Scientist's Toolkit: Key Research Reagents

The following table catalogues essential reagents and tools utilized in the cited studies for investigating E-cadherin and cytoskeletal biology.

Table 2: Essential Research Reagents for E-cadherin and Cytoskeleton Studies

Reagent / Tool	Function / Application	Example Use Case
MCF10A CDH1-/- Cell Line	Isogenic non-tumorigenic mammary epithelial model with engineered E-cadherin knockout.	Studying baseline consequences of E-cadherin loss without confounding oncogenic mutations [11].
CompoZr ZFN Technology	Zinc Finger Nuclease for precise gene editing.	Generation of homozygous CDH1 knockout cell lines [11].
Anti-E-cadherin Antibody	Immunodetection of E-cadherin protein (Western Blot, IF, IHC).	Validating E-cadherin knockout (Santa Cruz, SC7870) and assessing expression in tissues [11] [14].
Anti-α-Tubulin Antibody	Immunofluorescence staining of microtubule networks.	Visualizing and quantifying cytoskeletal architecture using computational pipelines [13].
Phase-Field/Vertex Models	Computational frameworks simulating cell-cell and cell-ECM interactions.	Modeling basal extrusion efficiency and role of tissue geometry in invasion [8].
MEK Inhibitor (e.g., PD98059)	Small molecule inhibitor of the MEK/ERK signaling pathway.	Investigating the functional link between E-cadherin loss and ERK activation [14].
siRNA for CDH1	Transient knockdown of E-cadherin gene expression.	Functional studies on proliferation, migration, and signaling upon E-cadherin loss [14].
NHC-diphosphate	NHC-diphosphate, MF:C9H15N3O12P2, MW:419.18 g/mol	Chemical Reagent
Wsf1-IN-1	Wsf1-IN-1, MF:C20H21F3N8O, MW:446.4 g/mol	Chemical Reagent

The body of evidence unequivocally demonstrates that E-cadherin loss initiates a cascade of cellular events extending far beyond weakened adhesion. It triggers profound cytoskeletal remodeling, alters ECM engagement, and activates potent pro-tumorigenic signaling pathways, collectively fostering an environment permissive for invasion. The phenotypic outcome—whether delayed migration or aggressive extrusion—is context-dependent, influenced by genetic background, ECM composition, and tissue architecture. For researchers and drug developers, targeting the vulnerabilities created by this unstable state, such as the heightened dependence on EGFR-MEK/ERK signaling or specific cytoskeletal regulators, presents a promising therapeutic strategy for combating E-cadherin-deficient cancers.

The cytoskeleton serves as the primary structural framework within cells, maintaining cellular integrity and facilitating critical processes including division, migration, and signal transduction. This dynamic network, composed of actin filaments, microtubules, and intermediate filaments, undergoes precise regulation to support cellular homeostasis. In pathological states, particularly cancer, this regulation falters. Mutations in E-cadherin, a crucial protein for cell-cell adhesion, are a well-documented driver of such dysfunction, leading to a loss of epithelial integrity and enhanced invasive potential [13] [15]. This review synthesizes current research to objectively compare cytoskeletal architectures—with a focus on actin stress fibers and microtubule networks—between wild-type and E-cadherin mutant cells. We provide a detailed analysis of quantitative morphological data, experimental protocols for assessing these cytoskeletal components, and the underlying signaling mechanisms, offering a resource for researchers and drug development professionals working in cancer biology and cell mechanics.

Comparative analysis of cytoskeletal organization

Actin architecture: From apical dominance to basal reorganization

In wild-type epithelial cells, actin networks are prominently organized into apical bundles, such as the actin belt that supports adherens junctions and helps maintain tissue-level cohesion [16]. However, research using intestinal epithelial models has revealed a more complex picture in differentiated cells. A distinct, star-shaped actomyosin network is assembled at the basal surface of cells within the differentiated domain of intestinal villi and villus-like organoid structures [16]. These so-called actin stars (AcSs) consist of a central actin node with approximately six radially projecting actin bundles, each about 5 μm in length, creating a supracellular lattice that underpins epithelial morphological stability [16].

The situation transforms significantly in cells with disrupted E-cadherin function. The loss of functional E-cadherin, a key suppressor of invasion, triggers a dramatic basal reorganization of the actin cytoskeleton [13]. The highly ordered AcS network gives way to prominent stress fibers, which are contractile bundles of F-actin and non-muscle myosin II [17]. These stress fibers are typically anchored at focal adhesions, large macromolecular assemblies that connect the cell to the extracellular matrix (ECM). This shift from a basal, stabilizing AcS network to stress fiber-dominated architecture enhances cellular contractility and generates the motile forces that drive cell migration, a hallmark of invasive cancer cells [17].

Microtubule patterning: From radial order to dispersed chaos

Microtubules, composed of α/β-tubulin heterodimers, are more than just structural elements; they are dynamic railways for intracellular transport and key players in establishing cell polarity. In wild-type cells, microtubules often exhibit a radial array, nucleating from a perinuclear microtubule-organizing center (MTOC) and extending towards the cell periphery [18]. This organized radiality is crucial for directed vesicle transport and maintaining directional persistence during migration [19].

Mutant E-cadherin cells exhibit a profound disruption in this orderly microtubule architecture. Quantitative computational analyses reveal that compared to wild-type cells, mutant cells possess microtubules that are shorter in length and display dispersed orientations [13]. The radial pattern centered on the nucleus is lost, replaced by a more compact distribution of microtubules throughout the cytoplasm. This disorganization is quantifiable through a significant decrease in the Orientational Order Parameter (OOP), a metric for fiber alignment, indicating a loss of overall directional order within the microtubule network [13]. This disrupted patterning is functionally linked to impaired cell polarity and uncontrolled, random migration.

Table 1: Quantitative Comparison of Cytoskeletal Features in Wild-Type vs. E-cadherin Mutant Cells

Cytoskeletal Feature	Wild-Type Cells	E-cadherin Mutant Cells	Measurement Method
Microtubule Orientation	Ordered, radial array [18]	Dispersed, disorganized orientations [13]	Orientational Order Parameter (OOP) [13]
Microtubule Length	Longer, extended fibers [13]	Shorter fibers [13]	Line segment extraction from fluorescence images [13]
Microtubule Distribution	Organized radiality from MTOC [18]	More compact cytoplasmic distribution [13]	Radiality score relative to nucleus centroid [13]
Prominent Actin Structure	Basal actin stars (differentiated epithelia) [16]	Stress fibers [17]	Immunofluorescence staining (e.g., Phalloidin) [17]
Actin Network Function	Morphological stability, limits protrusions [16]	Enhanced contractility, migration force generation [17]	Laser ablation, traction force microscopy [16]
Cell-Cell Adhesion	Strong, E-cadherin mediated [15]	Loss of E-cadherin function, weak adhesion [15]	Immunofluorescence, calcium chelation assays [16]

Methodological toolkit for cytoskeletal analysis

Experimental protocols for cytoskeletal phenotyping

1. Immunofluorescence and Microscopy for Cytoskeletal Visualization

• Cell Culture and Staining: Culture cells on appropriate substrates (e.g., glass coverslips). For mutant E-cadherin studies, a well-established model involves cells expressing a deleterious variant (e.g., p.L13_L15del) compared to wild-type controls [13]. Fix cells with paraformaldehyde, permeabilize with Triton X-100, and incubate with primary antibodies against α-tubulin (for microtubules) and E-cadherin [13]. Use fluorescent phalloidin to label F-actin for stress fiber visualization [17]. Mount samples for imaging.
• Image Acquisition: Acquire high-resolution z-stack images using a confocal microscope. For detailed cytoskeletal architecture, perform maximum intensity projection (MIP) of deconvoluted 2D images to enhance contrast and resolution [13].

2. Computational Pipeline for Cytoskeletal Feature Extraction This protocol, adapted from a Scientific Reports study, enables quantitative analysis of microtubule organization from fluorescence images [13].

• Preprocessing: Apply a Gaussian filter to smooth fluorescence signals and a Sato filter to highlight curvilinear structures of microtubules [13].
• Segmentation and Skeletonization: Use a Hessian filter to generate binary images of the cytoskeleton. Skeletonize these binary images to create a 1-pixel-wide representation of each fiber, allowing for precise measurement [13].
• Feature Extraction: Analyze the skeletonized images to extract Line Segment Features (LSFs) and Cytoskeleton Network Features (CNFs). Key quantifiable parameters include:
  • Orientational Order Parameter (OOP): Measures fiber alignment (lower values indicate disorganization) [13].
  • Fiber Length (LiE): The average length of cytoskeletal fibers.
  • Number of Lines (Nl): The quantity of polymerized fibers in a cell.
  • Compactness (Nl/Ac): The number of fibers per cell area.
  • Radiality Score (RS): Measures how fibers nucleate from the nucleus centroid [13].

3. Functional Assays: Wound Healing and Proteasome Degradation

• Wound Healing Assay: Culture cells to full confluence. Create a scratch ("wound") with a pipette tip. Monitor cell migration into the wound area over time using live-cell imaging. This assay evaluates the functional consequence of actin stress fiber formation on cell migration [20].
• Investigation of YAP/TAZ Mechanotransduction: To probe the mechanism linking microtubules to transcriptional activation, treat cells with drugs that depolymerize microtubules (e.g., nocodazole) or stabilize them. Analyze the localization of YAP/TAZ (e.g., immunofluorescence for nuclear/cytoplasmic ratio) and the protein levels of key regulators like AMOT (e.g., by western blot) following these treatments. This can reveal how microtubule architecture controls the dynein-dependent transport of AMOT to the pericentrosomal proteasome for degradation, a key step in mechano-signaling [18].

Key signaling pathways and mechanisms

The morphological shifts in the cytoskeleton are orchestrated by complex signaling pathways. The following diagram illustrates the core mechanism through which E-cadherin disruption and mechanical cues converge to reorganize microtubules and activate pro-tumorigenic transcription.

Figure 1: Microtubule-mediated mechanotransduction pathway in mutant E-cadherin cells. E-cadherin disruption and a stiff mechanical microenvironment trigger a shift from a peripheral microtubule cage to a radial array nucleated by the MTOC. This reorganization facilitates dynein-based transport of the YAP/TAZ inhibitor AMOT to the proteasome for degradation. AMOT degradation, opposed by the Hippo kinase LATS, frees YAP/TAZ to enter the nucleus and drive pro-tumorigenic transcription [18].

The experimental workflow for investigating this cytoskeletal reorganization integrates the protocols and reagents into a logical pipeline, from initial cell modeling to final data analysis, as shown below.

Figure 2: Experimental workflow for cytoskeletal analysis. The pipeline begins with establishing cellular models, followed by fluorescent staining and high-resolution imaging. Computational processing extracts quantitative features from the images, and functional assays validate the biological implications of the observed morphological shifts.

The scientist's toolkit: Research reagent solutions

Table 2: Essential Research Reagents for Cytoskeletal and Adhesion Studies

Reagent / Assay	Function / Specificity	Key Application in Research
Anti-E-cadherin Antibody	Binds to E-cadherin protein	Visualizing and quantifying adherens junctions and E-cadherin localization in wild-type vs. mutant cells via immunofluorescence [13] [15].
Anti-α-Tubulin Antibody	Binds to α-tubulin subunit	Labeling and assessing the overall microtubule network architecture, polymerization state, and organization [13] [18].
Phalloidin (Fluorescent)	High-affinity stain for F-actin	Visualizing actin stress fibers, cortical actin, and other F-actin structures; quantifying actin reorganization [17].
Nocodazole	Microtubule-depolymerizing agent	Experimentally disrupting microtubule networks to study their role in cell polarity, AMOT stability, and YAP/TAZ signaling [16] [18].
Latrunculin B	F-actin depolymerizing agent	Disrupting actin filaments to investigate their role in nuclear migration, cell mechanics, and YAP/TAZ regulation [21].
Anti-YAP/TAZ Antibody	Binds YAP and/or TAZ proteins	Determining the nucleo-cytoplasmic localization of YAP/TAZ, a key readout of mechanotransduction pathway activity [18] [17].
Wound Healing Assay Kit	Standardized tools for scratch assays	Functionally evaluating the migratory and invasive capacity of mutant E-cadherin cells compared to wild-type controls [20].
Computational Pipeline	Algorithm for fiber analysis	Quantifying complex cytoskeletal features (orientation, length, radiality) from fluorescence images [13].
Ac-FLTD-CMK	Ac-FLTD-CMK, MF:C26H37ClN4O8, MW:569.0 g/mol	Chemical Reagent
Kocurin	Kocurin, MF:C69H66N18O13S5, MW:1515.7 g/mol	Chemical Reagent

The comparative analysis between wild-type and E-cadherin mutant cells reveals a profound cytoskeletal reprogramming that is fundamental to the acquisition of an invasive phenotype. The shift from organized, basal actin stars to contractile stress fibers, coupled with the disintegration of radial microtubule arrays into disorganized, short filaments, creates a cellular architecture primed for motility and invasion [13] [16]. These morphological changes are not merely correlative; they are mechanistically driven by E-cadherin loss and the ensuing mechanical activation, which triggers a microtubule-dependent signaling cascade culminating in YAP/TAZ activation [18]. The quantitative methodologies and reagents outlined here provide a framework for ongoing research and drug discovery efforts aimed at targeting the cytoskeletal vulnerabilities of invasive cancer cells.

The loss of E-cadherin, a cornerstone of epithelial adhesion, triggers extensive transcriptional reprogramming that reshapes cell adhesion, extracellular matrix (ECM) interactions, and cytoskeletal architecture. This guide systematically compares the gene expression profiles and functional phenotypes between wild-type and E-cadherin-deficient cells. We synthesize experimental data from key studies to provide researchers and drug development professionals with a clear, evidence-based comparison of how E-cadherin knockout alters cellular machinery, supported by quantitative data, detailed methodologies, and pathway visualizations.

E-cadherin is a critical adherens junction protein that mediates homophilic, calcium-dependent cell-cell adhesion in epithelial tissues. Beyond its structural role, it functions as a tumor suppressor and a key signaling hub, interacting with both the actin cytoskeleton and microtubule networks to maintain cellular polarity and differentiation [22] [23]. Its cytoplasmic domain creates a bridge between the cytoskeletons of adjacent cells, while its extracellular domain facilitates cell-cell contact [24]. The loss of E-cadherin expression—through mutation, deletion, or promoter hypermethylation—is a well-established hallmark of epithelial-mesenchymal transition (EMT) and is observed in various carcinomas, including diffuse gastric cancer and lobular breast cancer [23]. However, emerging evidence suggests that the consequences of E-cadherin loss are complex and context-dependent, triggering a broad transcriptional reprogramming that extends beyond the acquisition of a mesenchymal phenotype [23] [24]. This guide objectively compares the alterations in adhesion and ECM gene expression following E-cadherin knockout, placing these findings within the broader context of cytoskeletal architecture research.

Key Molecular Alterations: E-Cadherin Knockout vs. Wild-Type

The functional inactivation of E-cadherin initiates a cascade of molecular changes. The tables below summarize the core phenotypic differences and key transcriptional changes identified in E-cadherin-deficient cells compared to their wild-type counterparts.

Table 1: Core Phenotypic Characteristics of E-Cadherin-Deficient Cells vs. Wild-Type

Parameter	Wild-Type (MCF10A)	E-Cadherin Knockout (MCF10A CDH1-/-)	Experimental Basis
Cell Morphology	Classic epithelial cobblestone appearance [23]	Subtle morphological changes, retained cell-cell contact [23]	Phase-contrast microscopy
Actin Cytoskeleton	Normal stress fibre distribution [23]	Thicker, more numerous basal stress fibres [23]	Fluorescence microscopy (F-actin stain)
Microtubule Network	Radial apical organization [23]	Loss of radial pattern, disorganized [23]	Fluorescence microscopy (α-tubulin stain)
Cell-Substrate Adhesion	Standard adhesion strength [23]	Weaker cell-substrate adhesion [23]	Adhesion assay with xCELLigence/IncuCyte
Cell Migration	Standard migration rate [23]	Delayed migration [23]	Migration assay with xCELLigence/IncuCyte
EMT Induction	Epithelial phenotype [23]	Insufficient for full EMT [23]	RNAseq & marker analysis (VIM, CDH2, FN1)

Table 2: Key Transcriptional Changes in Adhesion and ECM Genes in E-Cadherin Knockout Cells

Gene Category	Specific Gene	Expression Change in CDH1-/-	Function
Cell-ECM Adhesion	ITGA1	Downregulated [23]	Integrin subunit, cell-ECM adhesion
	COL8A1	Downregulated [23]	Collagen, ECM structural component
	COL4A2	Downregulated [23]	Collagen, basement membrane component
	COL12A1	Downregulated [23]	Fibrillar collagen, ECM organization
Proteolytic Enzymes	Matrix Metalloproteases (MMPs)	Upregulated [23]	Degradation of ECM components
	Kallikreins	Upregulated [23]	Serine proteases, ECM remodeling
Transcription Factors	c-Jun	Upregulated [24]	Component of AP-1 transcription factor
	Fra-1	Upregulated [24]	Component of AP-1 transcription factor
Classic EMT Markers	CDH2 (N-cadherin)	Unchanged [23]	Mesenchymal cadherin
	VIM (Vimentin)	Unchanged [23]	Mesenchymal intermediate filament
	FN1 (Fibronectin)	Unchanged [23]	Mesenchymal ECM glycoprotein

Experimental Protocols: Methodologies for Key Findings

Generation of an E-Cadherin Knockout Model

• Cell Line: The non-tumorigenic human mammary epithelial cell line MCF10A was used as the parental wild-type control [23].
• Gene Editing: A precise, isogenic E-cadherin knockout line (MCF10A CDH1-/-) was engineered using CompoZr Zinc Finger Nuclease (ZFN) technology to create a homozygous 4 bp deletion in exon 11 of the CDH1 gene [23].
• Validation: Successful knockout was confirmed via Western blot and immunofluorescence, showing a complete absence of E-cadherin protein expression in the CDH1-/- line compared to the wild-type control [23].

Genome-Wide Transcriptional Profiling

• RNA Sequencing: Whole-genome RNA sequencing (RNAseq) was performed on both wild-type and MCF10A CDH1-/- cells grown to confluence for 72 hours [23].
• Data Analysis: The RNAseq data was analyzed to identify differentially expressed genes, with a focus on pathways involved in cell-cell adhesion, cell-ECM adhesion, and EMT [23]. This approach provided an unbiased, comprehensive view of the transcriptional reprogramming resulting from E-cadherin loss.

Functional Cell-Based Assays

• Proliferation Assay: Growth rates of wild-type and knockout cells were monitored in real-time using the xCELLigence platform or the IncuCyte Live-Cell Analysis System [23].
• Adhesion Assay: Cell-substrate adhesion was quantified using the IncuCyte system. Cells were seeded onto plates with different ECM coatings, and adhesion strength was measured based on the rate of attachment and spreading [23].
• Cytoskeletal Analysis: For immunofluorescence, cells were seeded on coverglass slides, grown to confluence, fixed, and stained for F-actin (with phalloidin) and α-tubulin to visualize the microtubule network. Images were acquired using fluorescence microscopy [23].

Signaling Pathways and Transcriptional Networks

The diagram below illustrates the core transcriptional reprogramming events triggered by E-cadherin loss, based on the analyzed studies.

Diagram 1: Transcriptional reprogramming following E-cadherin loss. E-cadherin knockout triggers AP-1 activation, leading to specific gene expression changes and cytoskeletal disruption, without inducing a full EMT.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Reagents for E-Cadherin and Cytoskeletal Research

Reagent / Technology	Function / Application	Example Use Case
CompoZr ZFN Technology	Engineered nucleases for precise gene knockout.	Generation of isogenic MCF10A CDH1-/- cell line [23].
xCELLigence/IncuCyte	Real-time, label-free analysis of cellular processes.	Monitoring proliferation, migration, and adhesion [23].
RNA Sequencing	Comprehensive, unbiased transcriptome profiling.	Identification of differentially expressed genes [23].
Dominant-Negative E-Cadherin (Ec1WVM)	Protein that inhibits E-cadherin function.	Studying immediate and delayed effects of adhesion loss [24].
Anti-E-cadherin Antibody	Detect E-cadherin protein localization/expression.	Validation of knockout via immunofluorescence/Western blot [23].
α-Tubulin Antibody	Visualize microtubule network architecture.	Characterizing cytoskeletal organization [23].
Phalloidin Staining	Label F-actin for fluorescence microscopy.	Visualizing actin stress fibre formation and distribution [23].
Acremine I	Acremine I, MF:C12H16O5, MW:240.25 g/mol	Chemical Reagent
Sparsomycin	Sparsomycin	Sparsomycin is a universal protein synthesis inhibitor for research. It targets the ribosomal peptidyl transferase center. For Research Use Only (RUO). Not for human use.

Discussion: Implications for Research and Therapy

The data demonstrates that E-cadherin loss in a non-malignant background is insufficient to drive a full EMT, as classic mesenchymal markers like N-cadherin and vimentin remain unchanged [23]. Instead, it initiates a distinct transcriptional program characterized by the downregulation of key integrins and collagens, explaining the observed weaker cell-ECM adhesion. Concurrent upregulation of MMPs and kallikreins points toward an active, albeit incomplete, tissue remodeling program [23]. The activation of the AP-1 transcription factor complex (c-Jun, Fra-1) appears to be a pivotal early event in this reprogramming, linking the loss of adhesion to changes in gene expression and increased cell motility [24].

From a methodological perspective, the combination of precise gene editing, real-time functional assays, and genome-wide transcriptomic analysis provides a powerful framework for dissecting the complex phenotypes resulting from E-cadherin loss. The findings underscore that the role of E-cadherin extends far beyond being a simple glue between cells; it is a master regulator of epithelial integrity whose loss orchestrates a broad rewiring of adhesion and ECM gene expression. For drug development, targeting the specific pathways downstream of E-cadherin loss, such as AP-1 or the identified proteases, may offer new avenues for therapeutic intervention in cancers where E-cadherin is inactivated.

Quantitative Profiling of Cytoskeletal Dynamics: Computational and Imaging Pipelines

The cytoskeleton is a dynamic, three-dimensional network essential for maintaining cellular architecture, facilitating intracellular transport, and enabling cell migration. Disruptions in its organization are a hallmark of diseases like cancer, particularly in processes such as metastasis. The study of cytoskeletal architecture, especially in the context of cell adhesion molecules like E-cadherin, has been revolutionized by advanced immunofluorescence (IF) and 3D reconstruction techniques. These methods allow researchers to move beyond simple protein expression levels and quantify subtle, yet critical, structural alterations in components like microtubules and actin filaments. This guide compares the performance of current state-of-the-art imaging and analysis pipelines, providing the experimental data and protocols necessary to implement them effectively in research focused on cytoskeletal reorganization.

Comparative Performance of 3D Imaging and Analysis Techniques

Different methodological approaches offer distinct advantages for quantifying cytoskeletal features. The table below compares two advanced pipelines developed for the detailed analysis of cytoskeletal architecture.

Table 1: Performance Comparison of Cytoskeletal Analysis Pipelines

Analysis Feature	Computational Fiber Analysis Pipeline [13]	3D Colocalization & Simplification Pipeline [25]
Core Methodology	2D projection from Z-stacks; computational fiber segmentation and feature extraction.	3D surface rendering from stacked images; model simplification for efficient processing.
Key Measured Parameters	Fiber orientation (OOP), length, quantity, compactness, radiality, bundling [13].	3D colocalization coefficients, spatial overlap, object volume, and surface area [25].
Quantitative Findings	Mutant E-cadherin cells: ↓OOP (disoriented fibers), ↓fiber length, ↑compactness [13].	Enables precise quantification of protein colocalization in 3D space, avoiding 2D overestimation [25].
Best-Suited Application	High-content analysis of cytoskeletal network geometry and organization at a single-cell level.	Accurate visualization and quantification of spatial relationships between two proteins (e.g., FtMt/LC3) in 3D.
Software Tools	Custom algorithm with Gaussian, Sato, and Hessian filters; skeletonization [13].	IMARIS (3D rendering), MeshLab (model decimation) [25].
Impact on Cytoskeletal Research	Reveals unique "cytoskeletal signatures" associated with invasive phenotypes [13].	Enhances accuracy of 3D colocalization analysis by managing model complexity without quality loss [25].

Detailed Experimental Protocols

To ensure reproducible results, the following section outlines the key methodologies from the cited studies.

Protocol 1: Computational Fiber Analysis Pipeline

This protocol is designed for quantifying cytoskeletal architecture from 2D immunofluorescence images and was validated using cells with wild-type versus mutant E-cadherin [13].

• Cell Culture and Staining: Culture cells on appropriate substrates (e.g., laminin-coated dishes or micropatterned surfaces). Perform standard immunofluorescence staining for the cytoskeletal component of interest (e.g., α-tubulin for microtubules) and a nuclear marker (e.g., DAPI) [13].
• Image Acquisition: Acquire multiple Z-stack images using a confocal laser scanning microscope. Process the Z-stacks using maximum intensity projection (MIP) to generate 2D images for analysis [13].
• Image Preprocessing and Segmentation:
  • Apply a Gaussian filter to smooth the fluorescence signal and reduce noise.
  • Use a Sato filter to enhance and highlight the curvilinear structures of the cytoskeletal fibers.
  • Generate binary images using a Hessian filter.
  • Skeletonize the binary images to create a 1-pixel-wide representation of the fiber networks [13].
• Feature Extraction: The pipeline automatically extracts two classes of features from the skeletonized images:
  • Line Segment Features (LSFs): Describe fiber morphology, orientation, and quantity.
  • Cytoskeleton Network Features (CNFs): Describe network properties like connectivity, complexity, and radiality relative to the nucleus centroid [13].

Protocol 2: 3D Colocalization Model Rendering and Simplification

This protocol focuses on creating accurate and computationally manageable 3D models for colocalization studies, as demonstrated for FtMt and LC3 proteins [25].

• Tissue Preparation and Staining: Conduct double immunofluorescence staining on tissue sections or cells. For the cited study, deparaffinized human brain sections were used. After antigen retrieval, sections were incubated with primary antibodies (e.g., mouse anti-FtMt and rabbit anti-LC3), followed by species-specific secondary antibodies conjugated to different fluorophores (e.g., Alexa Fluor 555 and Alexa Fluor 488). A counterstain like DAPI is often included [25].
• Image Acquisition and 3D Rendering: Acquire Z-stacked images using a confocal microscope. Import the image stacks into IMARIS software and use the surface rendering module to create 3D models. Set the surface area detail level appropriately (e.g., 0.24 µm) and apply background subtraction thresholds [25].
• Model Simplification in MeshLab:
  • Export the 3D model from IMARIS in a compatible format (e.g., VRML 2.0) and open it in MeshLab.
  • To reduce model complexity, apply the Quadric Edge Collapse Decimation (QECD) filter. Set the desired final mesh size as a percentage of the original (e.g., 25%, 50%, 75%). The study found QECD superior to Clustering Decimation for preserving model quality [25].
  • For enhanced visualization of colocalization, apply the 'X-ray' shader within MeshLab, adjusting ambient, edge falloff, and intensity settings as needed [25].

Protocol 3: Optimized 3D Immunostaining for Large Specimens

Imaging large 3D specimens like multicellular tumor spheroids (MCTS) requires optimized protocols to ensure antibody penetration and homogeneous staining [26].

• Fixation and Permeabilization: Fix spheroids with 4% Paraformaldehyde (PFA) for 15 minutes at room temperature. Permeabilize with 0.3% Triton X-100 for 15 minutes. This combination was found to be superior to organic solvent-based methods (e.g., methanol/ethanol) [26].
• Antibody Staining: Incubate samples with primary and secondary antibodies diluted in a blocking solution. A critical optimization is to perform antibody incubations overnight (or for 4 hours) at 37°C with constant shaking (e.g., 600 rpm). This significantly improves antibody penetration compared to incubation at 4°C [26].
• Optical Clearing and Imaging: After staining, dehydrate spheroids using an ascending ethanol series (e.g., 30% to 100%, 2 minutes each). Clear the specimens by transferring them to BABB solution (1:2 benzyl alcohol: benzyl benzoate). Image the cleared spheroids using Light Sheet Fluorescence Microscopy (LSFM) for fast, high-quality 3D imaging with low photobleaching [26].

Table 2: Key Research Reagent Solutions for Cytoskeletal Imaging

Reagent / Solution	Function / Application	Example from Literature
Primary Antibodies	Label specific cytoskeletal proteins for visualization.	Mouse anti-α-tubulin [13] [26], Rabbit anti-LC3, Mouse anti-FtMt [25].
Fluorophore-conjugated Secondary Antibodies	Bind to primary antibodies to generate a fluorescent signal.	Alexa Fluor 488, Alexa Fluor 555, Alexa Fluor 568 [25] [26].
Tyramide Signal Amplification (TSA)	Enhance weak fluorescence signals for low-abundance targets.	Used with Alexa Fluor 555 tyramide for PD-L1 staining [27].
TrueBlack Lipofuscin Autofluorescence Quencher	Reduce background autofluorescence in tissue samples, improving signal-to-noise ratio.	Applied before mounting in IF protocols [25] [27].
BABB Clearing Solution	Render large biological specimens transparent for deep imaging.	Benzyl Alcohol / Benzyl Benzoate used for clearing spheroids in LSFM [26].
Butyl-Methyl Methacrylate (BMMA)	A plastic embedding medium for high-resolution immunofluorescence tomography of serial sections.	Preserves tissue morphology and allows sectioning for high Z-resolution [28].

Integration with E-cadherin Mutant Research

Advanced imaging directly links E-cadherin dysfunction to specific cytoskeletal rearrangements that drive invasion. Research shows that breast cancer cells with disrupted E-cadherin exhibit a noncohesive, invasive phenotype characterized by profound cytoskeletal disorganization.

Quantitative analysis using the computational pipeline revealed that compared to wild-type cells, mutant E-cadherin cells possess shorter microtubules with more dispersed orientations (lower OOP) and a more compact distribution of fibers [13]. Furthermore, the loss of the scaffolding protein Afadin, which stabilizes the link between E-cadherin and the actin cytoskeleton, induces a similar invasive phenotype. High-resolution 3D imaging of organoids has demonstrated that Afadin loss leads to immature adherens junctions, disrupted F-actin organization, and single-cell invasion, hallmarks of invasive lobular breast cancer [12]. These findings underscore how quantitative imaging can decode the biophysical mechanisms of metastasis.

The choice of imaging and analysis technique is critical for advancing our understanding of cytoskeletal biology in health and disease. Computational fiber analysis provides an unparalleled, high-content quantitative profile of cytoskeletal network geometry, ideal for phenotyping cells based on their mechanical state. In contrast, simplified 3D colocalization techniques offer superior accuracy for analyzing spatial protein interactions within the complex three-dimensional cellular space. For the specific study of E-cadherin and metastasis, these techniques have moved beyond correlation to reveal causal relationships between junctional integrity, cytoskeletal architecture, and invasive potential. As these protocols become more standardized and accessible, they will undoubtedly accelerate drug discovery by enabling the high-throughput quantification of cellular mechanophenotypes in response to therapeutic compounds.

The identification of cancer cells with invasive and metastatic potential remains a significant challenge in oncology research. In recent years, it has become evident that the organization of the cytoskeleton is dynamically orchestrated during cell transformation, though the impact of this remodeling is still largely unknown [13]. E-cadherin, a critical invasion suppressor protein, plays a determinant role in tumour development, with its deregulation being a major determinant of epithelial cell invasion and tumour progression [29]. In the context of Hereditary Diffuse Gastric Cancer (HDGC), germline mutations in the E-cadherin gene (CDH1) trigger a highly invasive cancer syndrome characterized by early dissemination of cancer cells [8].

This guide examines computational approaches for quantifying cytoskeletal architecture, focusing specifically on how these methods can objectively distinguish between wild-type and mutant E-cadherin cellular phenotypes. By comparing different computational feature extraction methodologies, we provide researchers with a framework for selecting appropriate analytical pipelines for investigating cytoskeletal reorganization in cancer progression, particularly in HDGC and related malignancies characterized by E-cadherin dysfunction.

Computational Feature Extraction Approaches

Bioimaging Pipeline for Cytoskeletal Analysis

A novel computational pipeline for characterizing cytoskeletal architecture has been developed to investigate fine-tuned cytoskeletal alterations in cancer cells with invasive potential [13]. This comprehensive framework employs a multi-stage image processing approach specifically designed to extract quantitative features from cytoskeletal components, with validation performed in E-cadherin mutant models.

The methodology begins with immunofluorescence images of cells stained for α-tubulin. Images undergo deconvolution to remove noise and blur, improving contrast and resolution. Multiple images are acquired for each channel along the Z-axis, with projection of Z-stacks through maximum intensity projection (MIP) applied to deconvoluted 2D images [13]. The processed images then undergo sequential filtering:

• Gaussian filtering to smooth the fluorescence signal of cytoskeletal components
• Sato filtering to highlight curvilinear structures
• Hessian filtering to generate binary images [13]

The resulting binary images are skeletonized to enable calculation of specific cytoskeletal parameters. Line segment rearrangements and graph networks serve as processing strategies for extracting two distinct feature classes: Line Segment Features (LSFs) and Cytoskeleton Network Features (CNFs), denoted by line segments and nodes, respectively [13]. Automatic nuclei segmentation is performed in parallel to define nuclei centroids and area, which are required for calculating nuclei-cytoskeletal ratios.

Feature Categories for Cytoskeletal Quantification

The computational pipeline extracts ten distinct cytoskeletal features that provide a comprehensive characterization of the cytoskeletal network:

Table 1: Cytoskeletal Feature Categories and Their Biological Significance

Feature Category	Description	Biological Significance
Orientation	Angular distribution (θi) of cytoskeletal fibers measured via Orientational Order Parameter (OOP)	Lower angular distribution indicates well-aligned fibers; disorganized fibers show wider angle range
Morphology	Fiber length and intercellular variability determined through Length Estimation (LiE)	Cells with higher fiber lengths typically show greater length variability
Quantity	Number of polymerized fibers (Nl) in a cell	Related to cell state and behavior; varies significantly between cells
Compactness	Number of fibers per cell area (Nl/Ac)	Measures whether fibers are dispersed or compactly distributed in cytoplasm
Radiality	Radial distribution pattern relative to nucleus centroid measured by Radial Score (RS)	Indicates how fibers nucleate from the cell center
Bundling	Degree of fiber bundling	Less effective at discriminating different cellular phenotypes
Parallelism	Extent of parallel fiber arrangement	Less effective at discriminating different cellular phenotypes
Connectivity	Network interconnection characteristics	Less effective at discriminating different cellular phenotypes
Complexity	Fractal dimension (FD) representing structural complexity	Shows similar values across cells with different phenotypes
Cytoskeleton-Nucleus Interconnection	Distance between fiber and nucleus centroids (Di)	Related to cell migration coordination between structures

Mathematical Morphology Methods

Mathematical morphology operations provide an alternative approach for analyzing cytoskeletal structures in biological images. These methods use structuring elements for probing and expanding shapes contained in input images, typically applied to binary or gray-scale images [30]. Key operations include:

• Erosion and dilation - fundamental operations that modify object boundaries
• Opening and closing - combinations of erosion and dilation that preserve size while smoothing contours
• Weighted-dilation operations - advanced implementations that maintain accuracy while improving crack continuity [30]

Unlike linear filter-based edge detection methods, morphological operations rely on non-linear filters that have less tendency to soften edges while filtering away high-frequency noise [30]. These methods work similarly to human perception but face challenges in manually determining appropriate size and structure of structuring elements. In practice, morphological operators are typically used as pre-processing or post-processing steps within a comprehensive detection pipeline rather than as standalone solutions [30].

Comparative Performance Analysis

Quantitative Discrimination of E-cadherin Mutant Phenotypes

The computational feature extraction pipeline has demonstrated significant utility in discriminating between wild-type and mutant E-cadherin cellular phenotypes. When applied to cells expressing wild-type E-cadherin versus a deleterious variant (p.L13_L15del) associated with HDGC, the method revealed distinct cytoskeletal organization patterns [13].

Table 2: Performance Comparison of Computational Features in Discriminating E-cadherin Mutant Phenotypes

Feature	Wild-Type E-cadherin	Mutant E-cadherin	Discriminatory Power
Microtubule Length	Longer fibers	Shorter fibers	High
Fiber Orientation	Organized patterns	Disperse orientations	High
Orientational Order Parameter (OOP)	Higher values	Significantly lower values	High
Compactness (Nl/Ac)	Less compact distribution	More compactly distributed	High
Radiality (RS)	Variable based on cell type	Disrupted radial patterns	Moderate
Fiber Quantity (Nl)	Cell state-dependent	Cell state-dependent	Low
Complexity (FD)	Similar across phenotypes	Similar across phenotypes	Low
Bundling/Parallelism	Limited variation	Limited variation	Low

Validation experiments confirmed that microtubules in cells with disrupted E-cadherin and increased invasive rates are shorter, have disperse orientations, and are more compactly distributed compared to their wild-type counterparts [13] [31]. These distinct microtubule signatures enable efficient recognition of cells with disseminating properties, providing potential diagnostic utility.

Methodological Comparison: Filter-Based vs. Morphology-Based Approaches

Different computational approaches offer varying advantages for cytoskeletal feature extraction:

Table 3: Comparison of Computational Methodologies for Cytoskeletal Analysis

Methodology	Advantages	Limitations	Best Application Context
Filter-Based Edge Detection (Canny, Sobel, Gabor)	Multi-stage algorithms detect wide edge ranges; good localization; minimal response [30]	Computation and memory-intensive; sensitive to simple spatial transformations; false detection from background irregularities [30]	Initial cytoskeletal fiber identification in high-quality images
Frequency Domain Filters (FFT, Wavelet, Gabor)	Frequency-selective; efficient for multi-directional, multi-scale detection [30]	Poor maintenance of crack continuity; adversely impacts spatial entirety leading to poor curvatures [30]	Analysis of periodic patterns in cytoskeletal organization
Mathematical Morphology	Non-linear filters preserve edges while removing noise; elegant operation similar to human perception [30]	Challenges in determining appropriate structuring elements; requires manual parameter tuning; rarely effective as standalone solution [30]	Pre-processing enhancement and post-processing refinement of cytoskeletal binaries
Combined Filter Approaches	Addresses limitations of individual methods; improves accuracy [30]	Increased complexity; requires optimization of multiple parameters	Final analysis stages where accuracy is prioritized over speed
Bioimaging Pipeline [13]	Comprehensive feature extraction; validated on E-cadherin models; multiple complementary filters	Specialized equipment required; complex implementation	Direct comparison of wild-type vs. mutant E-cadherin cytoskeletal architecture

Experimental Protocols for Cytoskeletal Analysis

Cell Culture and E-cadherin Mutant Models

For studies comparing wild-type and mutant E-cadherin, researchers have employed several established experimental models:

• MDA-MB-435S mammary carcinoma cells transfected with wild-type or tumor-derived mutant E-cadherin variants [32]
• CHO-K1 (Chinese Hamster Ovary) cells transduced with pcDNA3 mammalian expression vector encoding E-cadherin variants including A298T, T340A, P799R, and V832M, as well as wild-type E-cadherin or empty vector alone [29]
• Cancer cell lines expressing E-cadherin missense variants affecting different protein domains (e.g., extracellular A634V, juxtamembrane R749W, and intracellular V832M) [8]

Cells are typically grown in laminin-rich environments that provide supportive conditions for cell growth and cytoskeletal organization [13]. For extrusion assays, mutant cells labeled with fluorescent dye are mixed with wild-type cells at highly diluted ratios and cultured on top of collagen matrix, creating a monolayer system where one mutant cell is surrounded by wild-type neighbors [8].

Immunofluorescence and Image Acquisition

The protocol for cytoskeletal visualization includes these critical steps:

• Cell staining for nucleus and cytoskeletal component α-tubulin using appropriate immunofluorescence protocols [13]
• Image acquisition using multiple images for each channel along the Z-axis to create Z-stacks [13]
• Image deconvolution to remove noise and blur, improving contrast and resolution [13]
• Projection of Z-stacks through maximum intensity projection (MIP) in deconvoluted 2D images [13]

Image Processing Workflow

The computational feature extraction follows a sequential processing pipeline:

Figure 1: Computational Workflow for Cytoskeletal Feature Extraction

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Research Reagents for Cytoskeletal Architecture Studies

Reagent/Cell Line	Function/Application	Key Characteristics
MDA-MB-435S Mammary Carcinoma Cells	Model for E-cadherin transfection studies	E-cadherin-negative parental line; suitable for transfection with wt or mutant E-cadherin [32]
CHO-K1 Cells	Model for E-cadherin variant expression	Chinese Hamster Ovary cells; used for expression of E-cadherin variants A298T, T340A, P799R, V832M [29]
α-tubulin Antibodies	Immunofluorescence staining of microtubules	Target for cytoskeletal visualization; enables quantification of microtubule architecture [13]
Laminin-rich ECM	Supportive growth environment	Provides physiological context for cell growth and cytoskeletal organization [13]
Collagen Matrix	Extrusion assay substrate	Used in basal extrusion experiments to model cell-ECM interactions [8]
E-cadherin Mutant Variants	HDGC disease modeling	p.L13_L15del, A634V, R749W, V832M affecting different protein domains [13] [8]
Sulopenem	Sulopenem for Research|Thiopenem Antibiotic	Research-grade Sulopenem, a thiopenem antibiotic for studying multidrug-resistant infections. This product is For Research Use Only, not for human consumption.
Peldesine dihydrochloride	Peldesine dihydrochloride, MF:C12H13Cl2N5O, MW:314.17 g/mol	Chemical Reagent

Biological Implications and Signaling Pathways

E-cadherin dysfunction affects multiple signaling pathways that ultimately influence cytoskeletal organization. The computational feature extraction methods quantify the morphological manifestations of these molecular changes.

Figure 2: Signaling Pathways Linking E-cadherin Mutation to Cytoskeletal Changes

The relationship between E-cadherin mutation and cytoskeletal reorganization involves multiple interconnected pathways. E-cadherin dysfunction not only causes loss of cell-cell adhesion but also triggers activation of receptor tyrosine kinases (particularly EGFR), Src kinase, and p38 MAPK signaling pathways [29]. This signaling cross-talk leads to RhoA activation and increased actomyosin contractility [29] [33], which ultimately drives the cytoskeletal reorganization measurable through computational feature extraction.

Notably, different E-cadherin mutations produce distinct phenotypes. Extracellular domain mutants (e.g., T340A, A634V) demonstrate high migratory capacity, while intracellular variants (e.g., P799R, V832M) show different behaviors [29]. This genotype-phenotype correlation underscores the importance of domain-specific analyses when evaluating E-cadherin mutations.

Computational feature extraction methods for quantifying morphology, orientation, compactness, and radiality provide powerful tools for objectively analyzing cytoskeletal architecture in wild-type versus mutant E-cadherin research. The bioimaging pipeline described in this guide has demonstrated particular effectiveness in discriminating unique microtubule signatures associated with invasive potential, revealing that E-cadherin mutant cells exhibit shorter microtubules with dispersed orientations and more compact distribution compared to wild-type counterparts.

These computational approaches offer researchers robust, quantitative methods for investigating the relationship between E-cadherin dysfunction, cytoskeletal reorganization, and cancer cell invasion. As the field advances, integrating these feature extraction methods with molecular biology techniques will continue to enhance our understanding of metastatic processes and potentially identify new diagnostic biomarkers for aggressive cancers characterized by E-cadherin impairment.

Line Segment Features (LSF) and Cytoskeleton Network Features (CNF) for single-cell analysis

Analytical Comparison: LSF/CNF Pipeline vs. Alternative Computational Approaches

The following table compares a novel computational pipeline that utilizes Line Segment Features (LSFs) and Cytoskeleton Network Features (CNFs) against other established computational methods for quantifying cytoskeletal architecture in single-cell analysis [13].

Analytical Feature	LSF/CNF Pipeline [13]	Morphological & Actin Feature Extraction [34]	Diffusion Model Prediction [35]
Primary Focus	Microtubule architecture and network topology	Actin cytoskeleton and whole-cell morphology	Predicting actin stress fiber geometry from cell shape
Key Quantified Features	Fiber orientation (OOP), morphology (length), quantity (Nl), compactness (Nl/Ac), radiality (RS) [13]	Actin fiber parallelness, intensity, density; cell protrusions, aspect ratio, roughness [34]	Stress fiber distribution, alignment, localization probability [35]
Core Analytical Method	Line segment rearrangements and graph networks [13]	Supervised feature extraction and Support Vector Machines (SVM) [34]	Diffusion-based generative machine learning model [35]
Typical Input Data	Immunofluorescence images (α-tubulin stain) [13]	Confocal images (actin stain) [34]	Paired cell outline and actin stress fiber images [35]
Application in E-cadherin Research	Identified unique microtubule cues in E-cadherin mutant cells [13]	Not directly applied in the provided source	Not directly applied in the provided source
Reported Performance	Distinguished invasive cells with disrupted E-cadherin [13]	Up to 97% accuracy classifying cancer vs. non-cancer cell lines [34]	Predicted stress fiber distribution agrees well with experimental data [35]

Experimental Validation: Dissecting Cytoskeletal Alterations in E-cadherin Mutant Cells

The LSF/CNF pipeline was validated by analyzing the microtubule network in a well-established model of cells expressing wild-type E-cadherin versus a deleterious mutant (p.L13_L15del) associated with Hereditary Diffuse Gastric Cancer (HDGC), which leads to loss of cell-cell adhesion and a pro-invasive phenotype [13] [36]. The quantitative results are summarized below.

Cytoskeletal Feature	Wild-Type E-cadherin Cells	Mutant E-cadherin Cells	Biological Implication
Fiber Orientation (OOP)	Higher OOP values [13]	"Significantly lower OOP values" [13]	More disorganized and less aligned microtubules
Fiber Morphology (Length)	Information not explicitly stated in provided context	Shorter microtubules [13]	Altered polymerization dynamics or stability
Fiber Compactness (Nl/Ac)	Information not explicitly stated in provided context	More compactly distributed microtubules [13]	Denser cytoskeletal network architecture
Fiber Radiality (RS)	Information not explicitly stated in provided context	Disperse orientations [13]	Loss of coordinated, radial nucleation from nucleus

Detailed Experimental Protocol

1. Cell Culture and Staining:

• Cell Model: Cells expressing wild-type E-cadherin or a mutant variant (p.L13_L15del) associated with HDGC were used [13] [36].
• Growth Conditions: Cells were grown on laminin to provide a supportive ECM environment [13].
• Immunofluorescence: Cells were fixed and stained for the nucleus and the cytoskeletal component α-tubulin to visualize microtubules [13].

2. Image Acquisition and Preprocessing:

• Microscopy: Multiple images were acquired for each channel along the Z-axis [13].
• Z-stack Projection: Z-stacks were projected into 2D images using Maximum Intensity Projection (MIP) [13].
• Deconvolution: Images were deconvoluted to remove noise and blur, improving contrast and resolution [13].

3. Cytoskeletal Fiber Segmentation and Skeletonization:

• Filtering: Projected images were processed with a Gaussian filter to smooth the fluorescence signal [13].
• Highlighting Structures: A Sato filter was applied to highlight curvilinear structures corresponding to microtubules [13].
• Binarization: A Hessian filter was used to generate binary images of the cytoskeletal network [13].
• Skeletonization: Binary images were skeletonized to enable the calculation of specific cytoskeletal parameters, reducing fibers to single-pixel-wide representations for analysis [13].

4. Feature Extraction:

• Line Segment Features (LSFs): The skeletonized image was processed to extract line segments, quantifying features like fiber orientation, length, and quantity [13].
• Cytoskeleton Network Features (CNFs): The skeleton was also represented as a graph network of nodes and edges, allowing the quantification of network properties such as connectivity and complexity [13].
• Integrated Metrics: Additional features like compactness (number of fibers per cell area) and radiality (relative to the nucleus centroid) were calculated [13].

Visualizing the Computational Workflow

The following diagram illustrates the complete image analysis pipeline for extracting LSF and CNF, from raw imaging data to quantitative feature output.

Biological Workflow: From E-cadherin Dysfunction to Altered Cytoskeleton

The diagram below outlines the proposed biological mechanism connecting E-cadherin dysfunction to cytoskeletal remodeling and invasive behavior, as investigated using the LSF/CNF pipeline.

The Scientist's Toolkit: Essential Research Reagents and Materials

The table below lists key reagents and computational tools used in the featured experiments for analyzing cytoskeletal architecture.

Reagent / Tool	Function / Description	Application in Context
Anti-α-Tubulin Antibody	Immunofluorescence staining to label and visualize the microtubule network [13].	Used as the primary input for the LSF/CNF pipeline to segment and quantify microtubules [13].
Laminin Coating	Provides a supportive extracellular matrix (ECM) environment for cell growth, mimicking in vivo conditions [13].	Created a relevant microenvironment to study cell-ECM interactions in E-cadherin mutant cells [13].
Computational Pipeline (LSF/CNF)	A novel image-based algorithm for automated extraction of microtubule structural patterns [13].	The core methodology for dissecting unique cytoskeletal cues associated with invasive capacity [13].
Phase-Field Model	A mathematical/computational model simulating cell-cell and cell-ECM interactions in a tissue context [36].	Used to demonstrate that increased ECM attachment promotes basal extrusion of E-cadherin-deficient cells [36].
WM-3835	WM-3835, MF:C20H17FN2O4S, MW:400.4 g/mol	Chemical Reagent
Gsk-872 hydrochloride	Gsk-872 hydrochloride, MF:C19H18ClN3O2S2, MW:420.0 g/mol	Chemical Reagent

This guide objectively compares the application of a novel computational pipeline against pharmacological intervention for characterizing microtubule organization in wild-type versus mutant E-cadherin cellular models. E-cadherin disruption is a hallmark of epithelial-to-mesenchymal transition (EMT) in cancer progression, and precise analysis of the accompanying cytoskeletal remodeling is crucial for basic research and drug development. The following sections provide a detailed comparison of these methodological approaches, supported by experimental data and standardized protocols to enable implementation.

Methodological Comparison: Computational vs. Pharmacological Approaches

The two featured approaches answer distinct but complementary biological questions. The computational pipeline quantifies the basal, constitutive microtubule architecture resulting from E-cadherin loss, while pharmacological treatment probes the dynamic, functional relationship between microtubules and E-cadherin localization.

Table 1: Core Methodology Comparison

Feature	Computational Pipeline Approach	Pharmacological Intervention Approach
Core Principle	Automated image analysis to extract quantitative descriptors of microtubule architecture [31] [13]	Using microtubule-targeting agents (MTAs) to probe functional E-cadherin/microtubule signaling crosstalk [37]
Primary Output	Multidimensional profile of fiber organization (morphology, orientation, compactness) [13]	Assessment of E-cadherin relocalization to the cell cortex and associated signaling changes [37]
Key Question Answered	What is the structural phenotype of microtubules in E-cadherin-disrupted cells?	Can microtubule disruption actively reverse an EMT-associated phenotype?
Temporal Resolution	Steady-state (single time point)	Rapid dynamics (2-hour treatment) [37]
Throughput	High (automated single-cell analysis) [13]	Medium (requires immunofluorescence confirmation)

Experimental Data and Findings

Quantitative Profiling via Computational Pipeline

Application of the computational pipeline to a hereditary diffuse gastric cancer model (E-cadherin p.L13_L15del mutant vs. wild-type) revealed distinct microtubule signatures associated with the invasive, mutant phenotype [13].

Table 2: Microtubule Architecture in E-cadherin Wild-Type vs. Mutant Cells

Quantitative Feature	Wild-Type E-cadherin Cells	Mutant E-cadherin Cells	Biological Implication
Orientational Order Parameter (OOP)	Significantly higher [13]	Significantly lower [13]	Mutant cells have more disorganized, randomly oriented fibers.
Fiber Length & Morphology	Not specified (Used as reference)	Shorter microtubules [31]	Less stable or more fragmented microtubule network.
Fiber Compactness	Less compactly distributed [31]	More compactly distributed [31] [13]	Fibers are concentrated in a more confined cytoplasmic region.
Radiality Score	Variable (e.g., intermediate 0.302 to high 0.564) [13]	Not specified	In wild-type cells, radial nucleation from the nucleus can vary with cell phenotype.

Phenotypic Reversal via Pharmacological Intervention

Short-term (2-hour) treatment with microtubule-targeting agents (MTAs) promoted the redistribution of E-cadherin from internal pools to the cell cortex, a key feature of epithelial adhesion. This effect was most robust with microtubule destabilizers like eribulin and vinorelbine [37]. Mechanistic studies identified that eribulin disrupts the p130Cas/Src signaling complex at the cell cortex, leading to reduced Src phosphorylation. Since Src activity promotes E-cadherin internalization, its inhibition facilitates E-cadherin accumulation at the plasma membrane, effectively reversing a core EMT phenotype [37].

Detailed Experimental Protocols

Protocol 1: Computational Analysis of Microtubule Architecture

This protocol is adapted from the pipeline developed to dissect the cytoskeletal architecture of cancer cells with invasive potential [13].

Key Research Reagent Solutions:

• Cells: E-cadherin wild-type and mutant isogenic cell lines (e.g., HCC1937 TNBC cells) [13] [37].
• Antibodies: Primary antibody against α-tubulin for microtubule staining [13].
• Software: Image analysis software capable of Gaussian filtering, Sato filtering, Hessian filtering, and skeletonization (e.g., custom algorithms in Python or MATLAB) [13].

Workflow:

• Cell Culture and Staining: Culture cells on appropriate substrates (e.g., laminin). Fix and perform immunofluorescence staining for α-tubulin and the nucleus [13].
• Image Acquisition: Acquire high-resolution Z-stack images using a confocal microscope. Apply maximum intensity projection (MIP) to deconvoluted images to create 2D composites [13].
• Image Preprocessing: Process the tubulin channel with a Gaussian filter to smooth the signal, followed by a Sato filter to highlight the curvilinear structure of the fibers [13].
• Fiber Segmentation and Skeletonization: Apply a Hessian filter to generate a binary image of the cytoskeletal network. Skeletonize the binary image to create a 1-pixel-wide representation of each fiber [13].
• Feature Extraction: Analyze the skeletonized image to extract Line Segment Features (LSFs) and Cytoskeleton Network Features (CNFs). These include:
  • Orientational Order Parameter (OOP): Calculate from the angular distribution (θi) of all fibers. Lower OOP indicates disorganization [13].
  • Fiber Compactness: Calculate as the number of fibers (Nl) divided by the cell area (Ac) [13].
  • Fiber Length (LiE): Measure the average length and variability of fibers [13].
  • Radiality Score (RS): Quantify how fibers radiate from the nucleus centroid [13].

Protocol 2: Assessing E-cadherin Relocalization after MTA Treatment

This protocol is adapted from studies on the rapid promotion of cortical E-cadherin by microtubule-targeting agents [37].

Key Research Reagent Solutions:

• MTAs: Eribulin (microtubule destabilizer), Paclitaxel (microtubule stabilizer). Prepare stock solutions in DMSO and dilute to working concentrations in cell culture medium (e.g., 100 nM Eribulin, 1 μM Paclitaxel) [37].
• Inhibitors: Src kinase inhibitor (e.g., Dasatinib) for mechanistic studies [37].
• Antibodies: Antibodies for E-cadherin, β-tubulin, and phospho-Src for immunofluorescence and Western blot [37].

Workflow:

• Cell Seeding: Seed E-cadherin mutant or EMT-activated cells onto glass coverslips in a multi-well plate and allow to adhere [37].
• Drug Treatment: Treat cells with clinically relevant concentrations of MTAs (e.g., 100 nM eribulin, 1 μM paclitaxel) for 2 hours. Include a DMSO vehicle control [37].
• Cell Fixation and Staining: Fix cells with methanol (for microtubules) or paraformaldehyde (for other targets). Permeabilize with Triton X-100 and block with BSA. Perform immunofluorescence co-staining for E-cadherin and β-tubulin [37].
• Image Acquisition and Analysis: Acquire images using confocal microscopy. Quantify the shift of E-cadherin from a diffuse/cytoplasmic pattern to a sharp, continuous band at the cell cortex (cortical localization) [37].
• Mechanistic Validation (Optional): For hits like eribulin, perform co-immunoprecipitation to assess disruption of the p130Cas-Src complex or Western blot to analyze cortical Src phosphorylation levels [37].

The Scientist's Toolkit

Table 3: Essential Research Reagents and Their Applications

Reagent / Material	Function / Application	Specific Examples
Isogenic Cell Pairs	Gold-standard model to isolate E-cadherin mutation effects from other genetic variables.	E-cadherin WT vs. p.L13_L15del mutant cells [13].
Microtubule Destabilizers	Probe dynamic microtubule functions and induce cortical E-cadherin.	Eribulin, Vinorelbine [37].
Microtubule Stabilizers	Suppress microtubule dynamics; used for comparative mechanistic studies.	Paclitaxel, Docetaxel [37].
α-Tubulin Antibody	Primary antibody for visualizing the microtubule network via immunofluorescence.	Widely available from multiple suppliers [13].
E-Cadherin Antibody	Primary antibody for monitoring localization shifts during EMT/MTA treatment.	Monoclonal antibody against C-terminal region [38] [37].
Src Kinase Inhibitor	Tool for validating the role of Src signaling in E-cadherin trafficking.	Dasatinib [37].
PROTAC BRD4 Degrader-8	PROTAC BRD4 Degrader-8, MF:C53H61F2N9O11S2, MW:1102.2 g/mol	Chemical Reagent
Jak2-IN-7	Jak2-IN-7, MF:C26H33N7O, MW:459.6 g/mol	Chemical Reagent

Navigating Complex Phenotypes: Challenges in Modeling E-cadherin Dysfunction and Cytoskeletal Analysis

Epithelial-to-Mesenchymal Transition (EMT) represents a pivotal cellular program driving metastasis, chemoresistance, and tumor stemness in carcinoma progression. While the loss of E-cadherin, a key epithelial adhesion molecule, has long been considered a hallmark event initiating EMT, emerging evidence reveals a more complex reality. This review synthesizes recent findings demonstrating that E-cadherin dysfunction alone is frequently insufficient to驱动 a complete EMT program. We examine the critical contextual determinants—including cytoskeletal integration, tissue architecture, extracellular matrix interactions, and alternative degradation pathways—that modulate the functional consequences of E-cadherin loss. Through comparative analysis of experimental models and clinical data, we establish that E-cadherin's role in EMT must be understood within a broader signaling network, with important implications for targeting EMT therapeutically.

E-cadherin, a calcium-dependent cell-cell adhesion protein concentrated at adherens junctions, serves as a master regulator of epithelial integrity. Its extracellular domain facilitates homophilic interactions between adjacent cells, while its cytoplasmic tail connects to the actin cytoskeleton through catenin complexes (α-catenin, β-catenin, and p120-catenin), forming the core cadherin-catenin adhesion complex [39] [40]. The prevailing paradigm positions E-cadherin downregulation as a fundamental trigger for EMT, a developmental program co-opted by carcinomas to enhance invasiveness and metastatic potential. During EMT, cells lose apical-basal polarity, disassemble cell-cell junctions, and acquire mesenchymal characteristics including increased motility and resistance to apoptosis [39] [41].

However, translational studies and refined experimental models have challenged the sufficiency of E-cadherin loss in driving full EMT. In non-malignant breast cell lines (MCF10A), for instance, E-cadherin knockdown alone failed to induce a complete mesenchymal transition [39]. Similarly, in mammary epithelial cells (HB2), E-cadherin loss was identified as a consequence rather than a cause of c-erbB2-induced EMT [39]. Clinical observations further complicate this relationship, as certain invasive cancers (e.g., prostate, ovarian, and glioblastoma) maintain E-cadherin expression, suggesting context-dependent functions [39]. This article systematically compares experimental evidence to delineate the cellular and molecular contexts that determine whether E-cadherin dysfunction translates to full EMT or alternative phenotypic outcomes.

Molecular Architecture: E-Cadherin-Cytoskeleton Integration

The Core Adhesion Complex

The cadherin-catenin complex physically bridges the transmembrane E-cadherin with the actin cytoskeleton, constituting a fundamental mechanical linkage at adherens junctions. The cytoplasmic domain of E-cadherin binds β-catenin, which in turn associates with α-catenin, a bona fide F-actin binding protein. This connection is further stabilized by additional adaptors including vinculin, eplin, and zona occludens protein 1 (ZO1) [39] [40]. Recent research highlights that this molecular clutch is not merely static but exhibits remarkable mechanosensitivity, with force-dependent reinforcement crucial for mature adhesion formation [40].

Table 1: Key Components of the E-Cadherin Adhesome

Component	Localization	Primary Function	Consequence of Dysfunction
E-cadherin	Transmembrane	Calcium-dependent homophilic adhesion	Loss of cell-cell cohesion
β-catenin	Cytoplasmic	Links E-cadherin to α-catenin	Impaired complex assembly; potential nuclear signaling
α-catenin	Cytoplasmic	Binds F-actin; force-sensitive regulator	Defective cytoskeletal anchoring
Vinculin	Cytoplasmic	Force-dependent reinforcement of α-catenin	Weakened adhesion under mechanical stress
p120-catenin	Cytoplasmic	Stabilizes E-cadherin at membrane	Increased E-cadherin endocytosis/degradation

Actin Cytoskeletal Dynamics in EMT

The actin cytoskeleton exists in dynamic equilibrium at cell-cell junctions, with two primary pools identified: (1) junctional actin directly associated with cadherin complexes at contacting membranes, and (2) circumferential thin bundles aligned parallel to cell-cell contacts that regulate lateral height and junction configuration [42]. During productive EMT, coordinated reorganization of both pools is essential. Small GTPases (RhoA, Rac1, Cdc42) serve as pivotal regulators of these cytoskeletal rearrangements, with their spatial-temporal control determining epithelial plasticity outcomes [42]. When E-cadherin adhesion is compromised without concomitant cytoskeletal reprogramming, cells may fail to execute the coordinated morphological changes required for full mesenchymal transition.

Figure 1: Cytoskeletal Signaling Determines EMT Outcomes After E-cadherin Loss. Productive EMT requires coordinated GTPase-mediated cytoskeletal reorganization alongside E-cadherin disruption.

Experimental Evidence: Contextual Determinants of EMT Induction

Tissue Architecture and Extracellular Matrix Interactions

The physical microenvironment emerges as a critical determinant modulating EMT progression following E-cadherin dysfunction. Research on Hereditary Diffuse Gastric Cancer (HDGC), caused by germline E-cadherin mutations, demonstrates that the cylindrical architecture of gastric glands actively promotes early invasion [8]. Phase-field modeling and vertex simulations reveal that mutant E-cadherin cells exhibit increased basal extrusion efficiency when combined with enhanced ECM attachment, while absent ECM adhesion leads to apical extrusion instead of invasion [8].

Table 2: Experimental Models of E-cadherin Dysfunction and EMT Outcomes

Experimental System	E-cadherin Perturbation	EMT Outcome	Critical Contextual Factors
MCF10A breast cells [39]	Knockdown	No full EMT	Absence of additional EMT triggers
HB2 mammary cells [39]	c-erbB2-induced loss	Consequential, not causal	Oncogenic signaling primary driver
HDGC models [8]	Germline mutations	Basal extrusion/invasion	Enhanced ECM attachment; glandular architecture
GBM models [43]	Autophagic degradation	EMT promotion	AMPK/mTOR/ULK1-mediated autophagy activation
Colorectal cancer [44]	Expression loss	Poor prognosis	Combined with advanced TNM stage

Alternative E-cadherin Degradation Pathways

Beyond transcriptional repression, E-cadherin expression can be compromised through proteolytic cleavage and autophagic-lysosomal degradation, with distinct functional implications. In glioblastoma, transmembrane BAX inhibitor motif-containing 1 (TMBIM1) promotes EMT by accelerating autophagic degradation of E-cadherin via the AMPK/mTOR/ULK1 pathway [43]. Inhibition of autophagy in this context reversed TMBIM1-induced EMT, highlighting the importance of the degradation mechanism in determining phenotypic outcomes [43]. Additionally, soluble E-cadherin (80 kDa fragment) generated through proteolytic cleavage accumulates in cancer patients' serum and may function as a signaling molecule that promotes migration, proliferation, and survival [39].

The Signaling Network: Beyond Simple Cadherin Switching

Core EMT Transcription Factors and Signaling Pathways

EMT progression is orchestrated by a complex regulatory network encompassing multiple signaling pathways and transcription factors. Key pathways include TGF-β, WNT, NOTCH, and HIPPO, which converge on core EMT transcription factors (EMT-TFs) such as SNAIL, SLUG, TWIST, ZEB1, and ZEB2 [41]. These EMT-TFs form a hierarchical regulatory network that represses epithelial genes (including CDH1 encoding E-cadherin) while activating mesenchymal programs. The presence and activity of these regulators create permissive or restrictive environments for EMT induction following E-cadherin loss.

Figure 2: Signaling Context Determines EMT Outcomes. Multiple upstream pathways converge on EMT-TFs that can suppress E-cadherin, but cellular context filters the final phenotypic outcome.

Partial EMT and Hybrid States

Rather than a binary switch, EMT increasingly appears as a spectrum of intermediate states, often termed partial EMT (pEMT) or hybrid E/M states [41] [45]. Single-cell RNA sequencing analyses across multiple cancer types identify conserved genes upregulated in intermediate EMT states, including SFN (stratifin), ITGB4, ITGA6, and SNCG [45]. These hybrid states exhibit characteristics of both epithelial and mesenchymal phenotypes and may actually represent the most aggressive cellular phenotype in certain contexts, particularly for metastasis initiation [45]. The presence of these stable intermediate states further complicates the straightforward relationship between E-cadherin loss and complete mesenchymal transition.

Clinical Translation: Diagnostic and Therapeutic Implications

Prognostic Significance in Cancer Staging

The clinical relevance of E-cadherin expression patterns is evident in colorectal cancer, where integrating E-cadherin status with TNM staging enhances prognostic precision. Patients with low E-cadherin expression (E-cadherinLow) demonstrated significantly worse outcomes, with hazard ratios (HRs) of 2.30 for event-free survival and 2.76 for disease-specific survival compared to E-cadherinHigh patients [44]. When combined with TNM staging, stage III/IV patients with E-cadherinLow expression showed HRs of 1.93 for EFS and 2.35 for DSS compared to E-cadherinHigh patients at the same stage [44]. This underscores the clinical importance of E-cadherin as a biomarker when contextualized within established staging systems.

Therapeutic Targeting Considerations

The contextual dependence of E-cadherin function has profound implications for therapeutic strategies aimed at modulating EMT. Targeting EMT itself presents significant challenges due to its complexity, plasticity, and microenvironmental regulation [46]. Natural compounds with potential anti-EMT properties have been identified, but translating these discoveries to clinical applications remains challenging [39]. Alternative approaches might include targeting the downstream effectors of EMT-mediated immune suppression or the autophagy pathways responsible for E-cadherin degradation in specific contexts [43] [46].

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Reagents for Investigating E-cadherin Function in EMT

Reagent Category	Specific Examples	Research Application	Functional Insight
E-cadherin Antibodies	Anti-E-cadherin (e.g., ab40772)	IHC, WB, IF	Detection of expression/localization
E-cadherin Mutants	A634V, R749W, V832M	HDGC modeling	Domain-specific functional analysis
Autophagy Inhibitors	Chloroquine (CQ), 3-MA	Functional rescue experiments	Block autophagic E-cadherin degradation
Pathway Inhibitors	Compound C (AMPK inhibitor)	Signaling studies	AMPK/mTOR/ULK1 pathway dissection
ECM Components	Collagen matrices	3D culture/invasion assays	Cell-ECM interaction studies

Key Experimental Protocols

Basal Extrusion Assay

This protocol assesses the invasive potential of E-cadherin dysfunctional cells in a wild-type epithelial context, modeling early invasion events in HDGC [8].

• Cell Preparation: Engineer cancer cell lines to express HDGC-associated E-cadherin mutants (e.g., A634V, R749W, V832M) affecting different protein domains.
• Fluorescent Labeling: Label mutant cells with a fluorescent dye (e.g., CellTracker) for visualization.
• Co-culture Establishment: Mix labeled mutant cells with wild-type cells at low ratios (e.g., 1:100) and plate onto collagen matrices to create a confluent monolayer.
• Confocal Imaging: Capture high-resolution z-stack images using confocal microscopy after 48-72 hours of culture.
• Quantification: Analyze xz-sections to determine the position of mutant cell nuclei relative to the monolayer plane. Calculate the percentage of basally extruded cells.

Autophagy-Dependent EMT Induction

This protocol evaluates the role of autophagic E-cadherin degradation in EMT progression, particularly relevant in glioblastoma models [43].

• Genetic Manipulation: Transfect glioma cells (U87, U251) with TMBIM1 overexpression plasmids or shRNA constructs using liposomal transfection reagents.
• Autophagy Modulation: Treat cells with autophagy inhibitors (chloroquine, 3-MA) or AMPK pathway modulators (Compound C) 24 hours post-transfection.
• Protein Analysis: Harvest cells after 48 hours for Western blotting to assess E-cadherin, N-cadherin, vimentin, and LC3 levels.
• Functional Assays: Perform Transwell migration and invasion assays with Matrigel coating to quantify invasive capability.
• Validation: Use co-immunoprecipitation to verify E-cadherin interaction with autophagy machinery components.

The relationship between E-cadherin loss and EMT exemplifies the complexity of cellular phenotype regulation. While E-cadherin dysfunction undoubtedly facilitates epithelial plasticity, its capacity to drive full EMT is heavily constrained by cellular context. Cytoskeletal connectivity, tissue architecture, alternative degradation mechanisms, and signaling network status collectively determine whether E-cadherin impairment results in complete mesenchymal transition, partial EMT, or alternative adaptive states. Recognizing these contextual determinants is essential for developing effective therapeutic strategies that target EMT in metastatic disease. Future research should prioritize mapping the contextual thresholds that govern EMT progression, particularly through advanced modeling approaches that capture the dynamics of epithelial plasticity in physiologically relevant microenvironments.

The cytoskeleton, a complex and dynamic network of protein fibers, serves as the fundamental mechanical structure of the cell, dictating cell shape, facilitating intracellular transport, and coordinating cell migration. In recent years, it has become increasingly evident that the organization of the cytoskeleton is dynamically orchestrated during cell transformation, with fine-tuned alterations corresponding to critical cellular states such as increased invasive potential [13]. The identification of these subtle cytoskeletal adaptations remains a critical limitation in cell biology, contributing to challenges in early disease diagnosis and understanding fundamental cellular processes. Traditional manual analysis of cytoskeletal architecture is extremely labor-intensive, requires specialized expertise, and introduces subjective variability, hampering large-scale studies and reproducible quantification.

Fortunately, advanced computational approaches now enable automated segmentation and quantification of cytoskeletal fibers, overcoming these analytical limitations. These methods leverage deep learning architectures, sophisticated image processing algorithms, and standardized quantification metrics to provide objective, high-throughput analysis of fiber morphology, orientation, and organization. This guide objectively compares the performance of these automated strategies, with a specific focus on their application in cytoskeletal architecture research within the context of wild-type versus mutant E-cadherin cells—a well-established model for studying loss of cell-cell adhesion and increased invasive behavior in cancer research [13] [40]. By comparing the capabilities, performance metrics, and experimental requirements of these approaches, researchers can select optimal strategies for their specific investigative needs.

Computational Frameworks for Fiber Segmentation

Deep Learning-Based Segmentation Architectures

U-Net Architectures with Advanced Modules: The U-Net architecture, a convolutional network with encoder-decoder structure, has become a prevalent framework for medical image segmentation due to its ability to retain essential features with relatively fewer training resources [47]. Its effectiveness has been demonstrated in segmenting white matter fiber tracts in neuroscientific applications, outperforming conventional deterministic methods in both precision and robustness [47]. Recent innovations have enhanced the standard U-Net by incorporating specialized modules to address specific segmentation challenges.

The Dense-Inception Spatial Attention U-Net (DISAU-Net) represents one such advanced architecture, integrating three key components: Spatial Attention modules, Dense-Net connections, and GoogLeNet's Inception modules [47]. This hybrid approach increases network depth and width while maintaining computational efficiency. The Spatial Attention module enhances focus on relevant spatial features, DenseNet connections facilitate gradient flow through deeper networks, and the Inception-ResNet-V2 block allows the network to grow wider without vanishing gradient problems [47]. Experimental results demonstrate that this architecture outperforms earlier state-of-the-art approaches, particularly in handling complex fiber structures.

Semi-Supervised U-Net with Pre-training: For scenarios with limited manually annotated data—common in specialized biological research—a semi-supervised U-Net framework enhanced with pre-training strategies offers significant advantages [48]. This approach leverages abundant unlabeled data through self-supervised pre-training on an image reconstruction task, forcing the encoder to learn meaningful structural features before fine-tuning on labeled data for segmentation [48]. The network is trained using a combination of Binary Cross Entropy and Dice loss, or Focal and Dice loss, to address class imbalance and enhance overlap with ground truth. This strategy has demonstrated a 22% improvement in detecting sparse fiber bundles and reduced False Discovery Rate by 40% compared to previous state-of-the-art methods [48].

Table 1: Comparison of Deep Learning Architectures for Fiber Segmentation

Architecture	Key Components	Advantages	Limitations	Reported Performance
DISAU-Net [47]	Spatial Attention, DenseNet, Inception-ResNet-V2	Increased depth/width, stable gradient flow, focuses on relevant features	Higher computational complexity	Outperformed earlier state-of-the-art approaches in segmentation accuracy
Semi-Supervised U-Net [48]	Self-supervised pre-training, Focal+Dice loss	Effective with limited annotations, handles class imbalance	Requires strategic patch sampling	22% improvement in sparse bundle detection, 40% FDR reduction
Standard U-Net [48]	Encoder-decoder, skip connections	Proven reliability, simpler implementation	Limited with few annotations, may miss sparse features	Baseline performance, requires post-processing

Traditional Image Processing Pipelines

For researchers without extensive deep learning expertise or computational resources, traditional image processing pipelines offer a viable alternative for cytoskeletal fiber segmentation. These methodologies apply sequential preprocessing and processing steps to extract fiber structures from fluorescence images [13].

The standard workflow begins with image preprocessing including deconvolution to remove noise and blur, followed by application of specialized filters: Gaussian filters to smooth fluorescence signals, Sato filters to highlight curvilinear structures, and Hessian filters to generate binary images [13]. The resulting binary images are then skeletonized to enable calculation of specific cytoskeletal parameters.

The processed images undergo feature extraction through two complementary approaches: Line Segment Features (LSFs) and Cytoskeleton Network Features (CNFs). LSFs analyze individual fiber segments, while CNFs model the overall network topology using graph networks with nodes and edges [13]. This combined approach enables comprehensive characterization of cytoskeletal architecture through multiple quantitative descriptors.

Quantitative Metrics for Cytoskeletal Characterization

Automated segmentation enables quantification of cytoskeletal features through standardized metrics that provide objective assessment of fiber organization. These parameters can detect subtle differences between experimental conditions, such as wild-type versus mutant E-cadherin expression.

Table 2: Quantitative Metrics for Cytoskeletal Analysis [13]

Metric Category	Specific Parameters	Biological Significance	Application in E-cadherin Research
Orientation	Orientational Order Parameter (OOP), Angular Distribution	Measures fiber alignment and directionality	Mutant E-cadherin cells show significantly lower OOP, indicating disorganized fibers
Morphology	Fiber Length (LiE), Length Variability	Quantifies structural composition of fibers	Mutant cells exhibit shorter microtubules with altered length distribution
Quantity	Number of Fibers (Nl)	Measures polymerization extent	Varies with cell state and behavior
Spatial Distribution	Compactness (Nl/Ac), Radiality Score (RS)	Analyzes fiber density and distribution patterns	Mutant cells show more compact fiber distribution with altered radial organization
Nuclear Relationship	Fiber-Nucleus Distance (Di)	Indicates cytoskeleton-nucleus interconnection	Reflects coordination between cellular structures during migration

Research applying these metrics to E-cadherin mutant cells has revealed distinct cytoskeletal alterations consistent with increased invasive potential. Specifically, cells expressing mutant E-cadherin exhibit significantly lower Orientational Order Parameter values, indicating more disorganized fiber arrangements [13]. These cells also display shorter microtubules with more dispersed orientations and more compact distribution patterns compared to wild-type counterparts [13]. These quantitative differences demonstrate how automated segmentation and analysis can detect functionally relevant cytoskeletal alterations associated with disruptive mutations.

Experimental Protocols for Cytoskeletal Analysis

Sample Preparation and Imaging Workflow

Cell Culture and Transfection: The experimental pipeline begins with establishing appropriate cellular models. For E-cadherin studies, this typically involves comparing cells expressing wild-type E-cadherin with those expressing deleterious variants, such as the p.L13_L15del mutation associated with hereditary diffuse gastric cancer [13]. Cells should be grown on laminin-coated surfaces to provide a supportive environment for cell growth and proper cytoskeletal organization [13].

Immunofluorescence Staining: To visualize cytoskeletal components, cells are fixed and stained using antibodies specific to cytoskeletal proteins. For microtubule analysis, anti-α-tubulin antibodies are employed [13]. Simultaneous nuclear staining with DAPI or similar dyes enables subsequent analysis of cytoskeleton-nucleus relationships. For comprehensive network analysis, additional staining for actin filaments (using phalloidin) or intermediate filaments may be incorporated.

Image Acquisition: High-quality image acquisition is critical for successful automated analysis. Images of cells stained for nucleus and cytoskeletal components should be acquired as z-stacks using high-resolution fluorescence microscopy [13]. Multiple images should be collected for each channel along the Z axis, followed by maximum intensity projection (MIP) of deconvoluted 2D images to create a comprehensive representation of the cytoskeletal network while reducing out-of-focus light.

Computational Analysis Protocol

Image Preprocessing: The acquired images first undergo preprocessing to enhance segmentation quality. This includes:

• Deconvolution to remove noise and blur, improving contrast and resolution [13].
• Gaussian filtering to smooth the fluorescence signal of cytoskeletal components.
• Sato filtering to specifically highlight curvilinear structures corresponding to fibers.
• Hessian filtering to generate binary images from which the fiber network can be skeletonized [13].

Segmentation Implementation: Depending on the chosen approach:

• For deep learning methods, preprocessed images are divided into patches (e.g., 1024×1024 pixels) with stratified sampling to ensure balanced representation of foreground and background regions [48]. Data augmentation strategies including horizontal/vertical flips and elastic transformations are applied to improve model generalizability.
• For traditional image processing, binary images are skeletonized to enable calculation of cytoskeletal parameters. Line segment rearrangements and graph networks are used as processing strategies to automatically extract Line Segment Features and Cytoskeleton Network Features [13].

Parameter Quantification: The segmented fibers are analyzed to compute the quantitative metrics described in Table 2, enabling statistical comparison between experimental conditions (e.g., wild-type vs. mutant E-cadherin).

Research Reagent Solutions for Cytoskeletal Studies

Successful implementation of automated fiber segmentation requires appropriate experimental materials and reagents. The following table details essential research tools for cytoskeletal analysis in the context of E-cadherin and cell adhesion studies.

Table 3: Essential Research Reagents for Cytoskeletal Analysis

Reagent Category	Specific Examples	Research Function	Application Notes
Cell Line Models	Wild-type vs. mutant E-cadherin expressing cells	Provide cellular context for adhesion studies	E-cadherin p.L13_L15del mutant models loss of cell-cell adhesion [13]
Cytoskeletal Markers	Anti-α-tubulin antibodies, Phalloidin (for F-actin)	Visualize specific cytoskeletal components	Enable immunofluorescence staining of microtubules or actin filaments [13]
Extracellular Matrix	Laminin-coated surfaces	Provide physiological growth environment	Supports proper cell growth and cytoskeletal organization [13]
Secondary Reagents	Fluorescently-labeled secondary antibodies, DAPI	Enable multiplex visualization	Allow simultaneous detection of multiple structures (cytoskeleton, nucleus) [13]
Imaging Reagents	Mounting media, Antifade reagents	Preserve sample integrity during imaging	Maintain fluorescence signal during extended acquisition

Performance Comparison and Application Insights

Method Selection Guidelines

Choosing between deep learning and traditional image processing approaches depends on several factors specific to the research context:

Deep learning methods are particularly advantageous when analyzing complex, dense fiber networks where traditional algorithms struggle with overlapping structures. Their superior performance in detecting sparse fibers (22% improvement) and significantly lower false discovery rates (40% reduction) make them ideal for comprehensive cytoskeletal analysis [48]. However, they require substantial computational resources and careful hyperparameter tuning. The DISAU-Net architecture, with its enhanced feature extraction capabilities, is particularly suited for detecting subtle cytoskeletal alterations that may be missed by simpler approaches [47].

Traditional image processing pipelines offer greater interpretability and lower computational demands, making them accessible to researchers without specialized machine learning expertise. These methods perform adequately for well-defined fibers with clear contrast from background, but may struggle with complex, dense networks or subtle morphological variations [13]. They represent a practical starting point for laboratories beginning automated cytoskeletal analysis.

Biological Insights from Automated Analysis

The application of these automated methods to E-cadherin research has revealed fundamental insights into how cell adhesion molecules influence cytoskeletal organization. Quantitative analysis has demonstrated that E-cadherin mutation leads to shorter microtubules with dispersed orientations and more compact distribution [13], characteristics consistent with increased cell motility and invasive potential. These structural changes likely contribute to the disseminating properties of cells with disrupted cell-cell adhesion.

Automated segmentation further enables investigation of the dynamic interplay between cadherin adhesion complexes and the cytoskeleton. The cadherin-catenin complex serves as a critical bridge between neighboring cells and the actomyosin cytoskeleton, contributing to mechanical coupling that drives morphogenetic events and tissue repair [40]. The ability to quantitatively assess cytoskeletal reorganization in response to cadherin manipulation provides powerful insights into fundamental mechanisms of cell behavior and tissue organization.

Automated fiber segmentation and quantification strategies have dramatically advanced our ability to objectively analyze cytoskeletal architecture, overcoming the limitations of manual approaches. Deep learning methods, particularly advanced U-Net architectures, offer superior performance for complex segmentation tasks, while traditional image processing provides accessible alternatives for well-defined structures. The application of these methods to E-cadherin research has revealed specific cytoskeletal alterations associated with disrupted cell adhesion and increased invasive potential, providing insights into the fundamental relationship between adhesion molecules and cellular architecture. As these computational approaches continue to evolve, they will undoubtedly yield further insights into cytoskeletal dynamics in health and disease.

The interplay between cell-cell and cell-extracellular matrix (ECM) adhesions represents a fundamental regulatory node in epithelial homeostasis and cancer pathogenesis. Research into hereditary diffuse gastric cancer (HDGC), caused by germline mutations in the E-cadherin gene (CDH1), provides a paradigm-shifting model for understanding how E-cadherin dysfunction alters cytoskeletal architecture and cell-ECM interactions to drive invasion. In this syndrome, E-cadherin-defective cells display remarkably early invasive behavior, detected as isolated cancer cells infiltrating the adjacent stroma while the overall tissue architecture appears preserved [8]. This observation challenges simplistic models focused solely on loss of cell-cell adhesion and points to more complex interactions with the microenvironment.

The cytoskeleton serves as the critical integrator of mechanical and chemical signals between adherens junctions and ECM adhesions. E-cadherin, through its connection to the actin cytoskeleton via catenin complexes, not only maintains epithelial integrity but also regulates contact inhibition of proliferation [49]. When E-cadherin function is compromised, the resulting cytoskeletal rearrangements create permissive conditions for invasion through altered mechanotransduction and enhanced ECM engagement. This review synthesizes recent advances in modeling how increased matrix attachment cooperates with E-cadherin dysfunction to promote basal extrusion, the initial step in the invasive cascade.

Experimental Approaches: Methodologies for Investigating Cell-ECM Dynamics

In Vitro Modeling of E-cadherin Dysfunction

To mimic the early stages of HDGC, where isolated E-cadherin mutant cells arise within a normal epithelial context, researchers have developed a sophisticated monolayer assay system. This approach involves labeling MDA-MB-435S mammary carcinoma cells expressing HDGC-associated E-cadherin mutants (A634V, R749W, V832M) with fluorescent dyes and mixing them with wild-type cells at highly diluted ratios [8]. These cocultures are then grown on top of a collagen matrix, creating a system where individual mutant cells are surrounded by normal neighbors, accurately recapitulating the in situ pagetoid spread observed in patient specimens.

Key Experimental Protocol:

• Cell Lines: MDA-MB-435S mammary carcinoma cells transfected with wild-type or mutant E-cadherin (A634V, R749W, V832M)
• Matrix Substrate: Type I collagen matrix
• Experimental Setup: Fluorescently labeled mutant cells cocultured with wild-type cells at dilute ratios (1:100 or lower)
• Analysis Method: Confocal microscopy xz-sections to determine cell position relative to the monolayer
• Quantification: Measurement of basal versus apical extrusion percentages using nuclear positioning

This experimental design allows precise quantification of extrusion dynamics while controlling for cell-autonomous and non-autonomous effects, providing a robust platform for investigating how different E-cadherin mutations disrupt epithelial organization through distinct mechanisms.

Computational Modeling Approaches

Computational approaches have provided unprecedented insights into the biophysical principles governing extrusion processes. Researchers have implemented a multi-scale modeling strategy combining three complementary approaches:

Phase-Field Modeling: This technique represents the cell-ECM interface as a continuously evolving boundary, allowing simulation of complex morphological changes during extrusion. The model typically comprises 16 cells vertically arranged in a hexagonal lattice above an ECM layer, with one E-cadherin dysfunctional cell that cannot adhere to its neighbors [8]. Parameters such as cell-ECM adhesion strength, membrane tension, and cortical actin contractility can be systematically varied to determine their contribution to extrusion efficiency.

Vertex Model Simulations: These models represent tissues as interconnected polygons, with vertices moving in response to forces generated by cells and their environment. This approach has been particularly valuable for investigating how tissue architecture, specifically the cylindrical structure of gastric glands, influences invasive potential [8].

Dissipative Particle Dynamics (DPD): This coarse-grained molecular dynamics method simulates the behavior of soft matter systems over longer timescales, enabling validation of phase-field model predictions regarding cell movement and adhesion dynamics [8].

Table 1: Computational Modeling Approaches in Cell-ECM Research

Model Type	Key Features	Applications in E-cadherin Research
Phase-Field Modeling	Continuum representation of cell boundaries; captures complex morphologies	Simulates extrusion dynamics; tests effect of adhesion strength variations
Vertex Models	Network of interconnected polygons; emphasizes tissue geometry	Explores how glandular architecture promotes invasion
Dissipative Particle Dynamics	Mesoscale simulation of soft matter; bridges molecular and cellular scales	Validates extrusion mechanisms predicted by other models

Quantitative Findings: Data Integration from Experimental and Computational Studies

Basal Extrusion Rates of E-cadherin Mutants

The experimental coculture system has generated precise quantitative data on the extrusion potential of different E-cadherin mutants. When surrounded by wild-type cells, each mutant displays distinct extrusion behaviors, suggesting that different molecular mechanisms underlie their dysfunction:

Table 2: Experimental Extrusion Rates of E-cadherin Mutants

E-cadherin Variant	Domain Affected	Basal Extrusion Percentage	Apical Extrusion Percentage	Statistical Significance
Wild-type	-	Baseline	Baseline	-
A634V	Extracellular	18.63%	Increased	Not significant
R749W	Juxtamembrane	44.91%	Decreased	p = 0.0006
V832M	Intracellular	35.94%	Decreased	p = 0.04

Notably, the juxtamembrane R749W mutant, which causes complete loss of E-cadherin expression due to trafficking defects, exhibits the most pronounced basal extrusion phenotype, with nearly 45% of mutant cells invading the underlying matrix [8]. This suggests that complete absence of E-cadherin function generates the strongest pro-invasive signals. The inverse relationship between basal and apical extrusion—where mutants with high basal extrusion display low apical extrusion and vice versa—indicates that the direction of extrusion represents a fundamental fate decision point controlled by E-cadherin integrity.

Computational Analysis of ECM Adhesion Effects

Phase-field modeling has enabled rigorous quantification of how ECM adhesion strength influences extrusion dynamics. Systematic variation of cell-ECM adhesion parameters in silico reveals that:

• Mutant cells with increased cell-ECM adhesion demonstrate significantly greater traveled distances through the ECM and higher extrusion velocities [8].
• Even with normal ECM adhesion strength, E-cadherin deficient cells still undergo basal extrusion, albeit at reduced efficiency, indicating that loss of cell-cell adhesion alone can drive this process.
• In the complete absence of ECM adhesion, mutant cells are apically extruded, as wild-type neighbors with functional ECM attachments gradually displace them toward the lumen [8].

These computational findings identify ECM adhesion strength as a critical determinant of extrusion directionality, with strong attachment favoring basal invasion and weak attachment promoting apical elimination.

Molecular Mechanisms: Integrating Cytoskeletal Regulation and Mechanotransduction

Signaling Pathways Linking E-cadherin to Cytoskeletal Reorganization

The molecular machinery connecting E-cadherin dysfunction to increased ECM attachment involves multiple interconnected signaling pathways that collectively reprogram the cytoskeleton:

Diagram 1: E-cadherin loss signaling to extrusion

E-cadherin-mediated cell-cell contacts normally activate the growth-suppressive Hippo pathway through NF2/merlin, leading to phosphorylation and cytoplasmic retention of YAP/TAZ transcriptional coactivators [49]. Loss of E-cadherin function disrupts this signaling, permitting YAP/TAZ nuclear translocation and expression of proliferative and invasive genes. Simultaneously, E-cadherin dysfunction triggers actin cytoskeletal remodeling, enhancing contractility and promoting the formation of mature focal adhesions through recruitment of proteins like vinculin [8] [50].

Vinculin as a Mechanical Integrator

Vinculin has emerged as a key mechanosensitive component at the interface between the cytoskeleton and ECM. In vascular smooth muscle cells, vinculin demonstrates a complex relationship with matrix stiffness—while gene expression decreases on stiffer substrates (2-50 kPa), protein expression increases, suggesting post-translational regulation that enhances mechanical signaling at focal adhesions [50]. This stiffness-sensitive regulation likely extends to epithelial systems, where vinculin stabilizes integrin-cytoskeleton linkages, reinforcing ECM attachments specifically in E-cadherin-deficient cells.

Critical experiments disrupting the cytoskeleton-FA connection have demonstrated that cell detachment under shear stress typically occurs at the interface between focal adhesion proteins and the actin cytoskeleton, rather than at the integrin-ECM bond itself [51]. Cytoskeletal stabilization through pharmacological agents (e.g., phalloidin) or temperature reduction increases attachment strength by up to eightfold, highlighting the dynamic nature of this connection and its importance in determining adhesion strength [51].

The Scientist's Toolkit: Essential Research Reagents and Methodologies

Table 3: Key Research Reagents and Experimental Tools

Reagent/Assay	Function/Application	Experimental Context
Collagen I Matrix	ECM substrate for 2.5D and 3D culture	Provides physiological relevant attachment surface [8]
E-cadherin Mutant Constructs	A634V, R749W, V832M variants	Domain-specific functional analysis [8]
Phase-Field Modeling	Computational simulation of cell morphology	Predicts extrusion dynamics based on biophysical parameters [8]
Spinning Disk Shear Assay	Quantitative adhesion strength measurement	Applicable across cell types; reveals cytoskeletal role in adhesion [51]
Hydrogel Matrices with Tunable Stiffness	2-50 kPa elastic moduli	Simulates physiological and pathological tissue mechanics [50]
Vinculin Antibodies	Protein localization and expression analysis	Visualizes focal adhesion maturation and distribution [50]

Discussion: Synthesis and Research Implications

The integrated experimental-computational approach to modeling cell-ECM interactions has fundamentally advanced our understanding of early invasion in HDGC and other E-cadherin-deficient cancers. The evidence consistently demonstrates that basal extrusion requires two coordinated hits: (1) loss of E-cadherin-mediated cell-cell adhesion, and (2) enhanced attachment to the ECM through cytoskeletal reprogramming. This dual requirement explains why only a subset of E-cadherin mutant cells successfully invade, while others may be eliminated through apical extrusion or other mechanisms.

The cylindrical architecture of gastric glands emerges as an important topological factor that further promotes invasion, as demonstrated by vertex model simulations [8]. This structural consideration highlights the importance of modeling physiological tissue contexts rather than relying solely on simplified 2D systems. Similarly, the mechanical properties of the ECM—including its stiffness, viscoelasticity, and composition—create permissive or restrictive microenvironments that can either facilitate or impede invasion [52].

From a therapeutic perspective, the critical role of the cytoskeleton-ECM interface suggests potential intervention points. Rather than targeting E-cadherin loss itself, which has proven challenging, strategies that modulate the downstream cytoskeletal rearrangements or ECM interactions might normalize cell behavior and prevent invasion. The quantitative frameworks established through phase-field modeling and related computational approaches provide valuable platforms for simulating these interventions before embarking on costly experimental campaigns.

The modeling of cell-ECM interactions in E-cadherin-deficient contexts has evolved from descriptive observations to predictive computational frameworks that integrate molecular, cellular, and tissue-level dynamics. The consistent finding across experimental and computational approaches is that increased matrix attachment, mediated through cytoskeletal reorganization, represents a necessary permissive condition for basal extrusion and subsequent invasion. This mechanistic understanding reframes invasion as a multicomponent process involving not just loss of cell-cell adhesion but active reprogramming of cell-ECM interactions, offering new avenues for diagnostic and therapeutic innovation in HDGC and related malignancies.

E-cadherin serves as a critical regulator of epithelial integrity, functioning as a transmembrane adhesion protein that maintains tissue architecture through calcium-dependent homophilic binding. The structural organization of E-cadherin comprises three distinct domains: an extracellular domain consisting of five cadherin repeats (EC1-EC5) responsible for homophilic interactions, a single-pass transmembrane domain, and a cytoplasmic tail that connects to the actin cytoskeleton via catenin complexes [53]. Germline mutations in the CDH1 gene, which encodes E-cadherin, cause Hereditary Diffuse Gastric Cancer (HDGC), a highly invasive cancer syndrome characterized by early dissemination of signet ring cells [36]. In HDGC, E-cadherin-deficient cells detach from epithelial monolayers and exhibit basal extrusion into the extracellular matrix (ECM), representing the initial step in the invasive process [36].

The domain-specific localization of E-cadherin mutations significantly influences cellular behavior and extrusion potential. Different domains mediate distinct aspects of E-cadherin function, ranging from adhesive binding to cytoskeletal coupling and downstream signaling. This domain-specific functional specialization means that mutations affecting different regions of the protein can produce varied phenotypic outcomes in terms of extrusion direction, invasion capability, and ultimately, clinical progression. Understanding these mutation-specific effects provides crucial insights into the mechanisms underlying early cancer dissemination and may inform targeted therapeutic strategies for HDGC and related epithelial malignancies.

Domain-specific mutation effects on extrusion potential

Quantitative comparison of extrusion behavior by E-cadherin domain mutants

Experimental evidence demonstrates that different E-cadherin domain mutations yield distinct extrusion phenotypes, with significant implications for invasive potential. Research using engineered cell lines expressing HDGC-associated E-cadherin mutants revealed marked differences in extrusion behavior depending on the affected protein domain [36].

Table 1: Extrusion potential of E-cadherin domain mutants in a wild-type epithelial context

E-cadherin Mutation	Domain Affected	Basal Extrusion Percentage	Apical Extrusion Percentage	Statistical Significance
A634V	Extracellular	18.63%	Higher than other mutants	Not significant
R749W	Juxtamembrane	44.91%	Lower than A634V	p = 0.0006
V832M	Intracellular	35.94%	Lower than A634V	p = 0.04
Wild-type	-	Baseline	Baseline	Reference

The juxtamembrane R749W mutant, which causes trafficking deregulation and loss of E-cadherin expression, demonstrated the highest basal extrusion potential at 44.91% [36]. This was followed by the intracellular V832M mutant (35.94%), while the extracellular A634V mutant showed basal extrusion levels (18.63%) most similar to wild-type E-cadherin [36]. The inverse relationship was observed for apical extrusion, with A634V exhibiting higher apical extrusion levels compared to the juxtamembrane and intracellular mutants [36].

Mechanistic basis for domain-specific extrusion behaviors

The variation in extrusion behavior across E-cadherin domains stems from their distinct molecular functions and interactions within the cellular adhesion machinery.

Extracellular domain mutations: The A634V mutation affects the extracellular cadherin repeats primarily involved in homophilic adhesion. While this compromises intercellular adhesion, it preserves some connections to the intracellular signaling apparatus, resulting in a less pronounced basal extrusion phenotype compared to other domains [36].

Juxtamembrane domain mutations: The R749W mutation impacts the juxtamembrane domain, which regulates E-cadherin trafficking and stability. This mutation leads to complete loss of E-cadherin expression through trafficking deregulation, explaining its strong basal extrusion phenotype [36]. The juxtamembrane domain interacts with p120-catenin, which stabilizes E-cadherin at the membrane and regulates actin dynamics [53].

Intracellular domain mutations: The V832M mutation affects the intracellular domain, which directly interacts with β-catenin and links E-cadherin to the actin cytoskeleton [53]. Disruption of this connection not only impairs adhesion but also dysregulates actomyosin contractility and force transduction, leading to intermediate basal extrusion levels [36].

Molecular mechanisms linking E-cadherin dysfunction to extrusion

Signaling pathways regulating extrusion direction and efficiency

The direction of cell extrusion—apical versus basal—represents a critical determinant of disease progression. Apical extrusion typically results in cell elimination, while basal extrusion enables invasion into the underlying stroma [36]. Multiple interconnected pathways regulate this process, with E-cadherin playing a central role.

Table 2: Molecular pathways and their roles in E-cadherin-mediated extrusion

Pathway/Component	Role in Extrusion	Effect of E-cadherin Disruption
Actomyosin contractility	Generates mechanical force for extrusion	Increased myosin light chain phosphorylation elevates contractility [54]
ECM attachment	Determines extrusion direction	Enhanced integrin-mediated adhesion promotes basal extrusion [36]
N-WASP distribution	Regulates actin stability at junctions	Redistributes from apical to lateral zones, increasing lateral tension [33]
Cell-ECM adhesion strength	Influences extrusion efficiency	Stronger ECM attachment increases extrusion distance and velocity [36]
ROCK signaling	Mediates actomyosin contractility	Inhibition rescues adhesion of E-cadherin-deficient cells [54]

E-cadherin loss triggers a cascade of mechanical and biochemical changes that collectively promote basal extrusion. The redistribution of N-WASP from apical to lateral zones stabilizes F-actin in lateral regions, increasing contractility at the basal aspect and driving cells downward into the ECM [33]. Concurrently, E-cadherin-deficient cells exhibit enhanced attachment to ECM components through upregulated integrin signaling, providing the traction necessary for basal extrusion [36]. These coordinated changes in cytoskeletal organization and adhesion molecules create a permissive environment for invasion.

Computational modeling reveals structural contributions to extrusion

Phase-field modeling and vertex simulations have provided crucial insights into how tissue architecture influences extrusion behavior. Computational approaches demonstrate that the cylindrical structure of gastric glands strongly promotes the invasive ability of E-cadherin dysfunctional cells [36]. These models reveal that loss of cell-cell adhesion alone can induce basal extrusion through associated downstream signaling or mechanotransduction outputs, even without increased ECM attachment [36]. However, when mutant cells exhibit enhanced adhesion to ECM fibers, their extrusion becomes more efficient, with increased traveled distances and velocity through the matrix [36].

Diagram 1: Molecular pathways linking E-cadherin domain mutations to extrusion outcomes. Domain-specific mutations disrupt distinct aspects of E-cadherin function, converging on increased actomyosin contractility and altered adhesion properties that collectively promote basal extrusion.

Methodologies for investigating E-cadherin mutation effects

Experimental models and protocols for extrusion assays

Research into E-cadherin-mediated extrusion employs sophisticated experimental models that recapitulate the tissue context of mutation carriers. The primary methodology involves diluted co-culture systems where fluorescently labeled E-cadherin mutant cells are mixed with wild-type cells at highly diluted ratios and cultured on top of a collagen matrix [36]. This setup creates a monolayer system in which individual mutant cells are surrounded by wild-type neighbors, mimicking the random appearance of E-cadherin defective cells in normal gastric epithelium during early HDGC stages [36].

The experimental workflow typically includes:

• Engineering cancer cell lines expressing E-cadherin missense variants affecting different protein domains
• Fluorescent labeling of mutant cells for tracking
• Mixing mutant and wild-type cells at diluted ratios (approximately 1:100)
• Culturing the mixed population on collagen matrices for 24-72 hours
• Confocal microscopy with xz-sections to determine cell position relative to the epithelium
• Quantification of apical versus basal extrusion events across multiple fields

This approach enables researchers to directly compare the extrusion behavior of different E-cadherin mutants while controlling for environmental factors and cellular context. The method specifically assesses cell-autonomous effects of E-cadherin mutations while accounting for influences from wild-type neighboring cells.

Computational modeling approaches

Complementary to experimental assays, computational models provide powerful tools for investigating the biophysical principles underlying extrusion behavior. Phase-field modeling simulates epithelial dynamics and cell-ECM interactions, typically representing 16 cells vertically aligned in a hexagonal lattice above an ECM layer [36]. These models incorporate parameters such as cell-cell adhesion strength, cell-ECM adhesion, and cortical tension to predict extrusion outcomes.

Vertex model simulations explore how tissue architecture influences invasion, particularly demonstrating that the cylindrical structure of gastric glands promotes invasive ability [36]. Dissipative particle dynamics (DPD) simulations further validate findings by modeling cell movement and adhesion at different scales [36]. These computational approaches allow systematic manipulation of parameters that are challenging to control experimentally, providing mechanistic insights into the physical determinants of extrusion.

The scientist's toolkit: Essential research reagents and methodologies

Table 3: Key research reagents and experimental solutions for E-cadherin extrusion studies

Reagent/Method	Specific Example	Research Application	Experimental Function
Cell Culture Models	MDCK cells, Caco-2 cells, MCF-10A cells	Epithelial monolayer studies	Provide standardized epithelial systems for extrusion assays [55] [33]
Extracellular Matrix	Collagen I, Laminin, Collagen IV	ECM interaction studies	Substrate for evaluating basal extrusion and invasion potential [36] [54]
Inhibitors	Y-27632 (ROCK inhibitor), Blebbistatin	Contractility modulation	Relax actomyosin contractility to assess mechanical contributions [54]
Fluorescent Reporters	mTmG reporter system, GFP/RFP tags	Cell tracking and lineage tracing	Visualize and quantify mutant cell behavior in wild-type context [36] [54]
Computational Models	Phase-field models, Vertex models	Theoretical extrusion studies	Predict extrusion outcomes based on physical parameters [36]
Antibodies	Anti-E-cadherin, anti-β-catenin, anti-p120	Junction integrity assessment	Verify E-cadherin complex disruption and protein localization [53] [54]

The domain-specific effects of E-cadherin mutations on extrusion potential highlight the complex relationship between genotypic variation and phenotypic outcome in HDGC. The juxtamembrane domain emerges as particularly critical, with R749W mutations driving the highest rates of basal extrusion through complete loss of E-cadherin expression. Meanwhile, intracellular domain mutations disrupt connections to the cytoskeleton, and extracellular mutations primarily affect adhesion with less dramatic extrusion consequences.

These findings suggest potential therapeutic avenues targeting the downstream effectors of E-cadherin dysfunction rather than the genetic lesions themselves. The consistent elevation of actomyosin contractility across E-cadherin mutants indicates ROCK inhibition as a promising strategy to counteract extrusion and invasion [54]. Similarly, interventions modulating ECM interactions may specifically impede the basal extrusion promoted by enhanced matrix attachment [36]. Future research exploring combination approaches that address both mechanical and adhesive consequences of E-cadherin loss may yield effective strategies for preventing invasion in HDGC mutation carriers.

Phenotypic Validation and Comparative Analysis of Cytoskeletal Alterations in Disease Models

E-cadherin, a cornerstone of epithelial integrity, functions as a critical tumor suppressor by mediating homophilic cell-cell adhesion at adherens junctions. Its intracellular domain forms a molecular bridge linking adjacent cells' cytoskeletons through interactions with catenin proteins and cortical actin networks [38] [56]. The loss of functional E-cadherin, whether through mutational inactivation, transcriptional downregulation, or promoter hypermethylation, constitutes a hallmark of invasive lobular breast cancer and diffuse gastric carcinoma, and is a key step in epithelial-to-mesenchymal transition (EMT) [56] [57]. Emerging research now reveals that E-cadherin disruption precipitates extensive reorganization of the intracellular cytoskeleton, creating distinct architectural signatures associated with invasive potential. The cytoskeleton—comprising microtubules, actin filaments, and intermediate filaments—transcends its structural role to actively direct cellular processes including polarization, migration, and invasion [13] [58]. This guide systematically compares the cytoskeletal architectures, with particular emphasis on microtubule organization, between wild-type and E-cadherin mutant cells, providing quantitative data, methodological protocols, and analytical frameworks to advance research in cancer cell biology and therapeutic development.

Quantitative Comparison of Cytoskeletal Features

Table 1: Comprehensive comparison of cytoskeletal features between wild-type and E-cadherin mutant cells

Cytoskeletal Feature	Wild-Type E-Cadherin Cells	E-Cadherin Mutant/Deficient Cells	Experimental Method	Biological Implication
Microtubule Orientation	Higher Orientational Order Parameter (OOP ≈ 0.475) indicating aligned fibers [13]	Lower OOP values indicating disorganized, disperse orientations [13]	Computational analysis of angular distribution (θi) from immunofluorescence [13]	Loss of directional persistence in migration [13]
Microtubule Length	Longer fibers with higher intercellular variability [13]	Shorter fibers with more uniform length patterns [13]	Line Segment Extraction (LiE) algorithm [13]	Compromised intracellular transport and protrusion stability [59]
Microtubule Compactness	Lower fiber density (e.g., 0.421 μm⁻²) with dispersed cytoplasmic distribution [13]	Higher compactness (e.g., 2.039 μm⁻²) with densely packed fibers [13]	Number of lines per cell area (Nl/Ac) calculation [13]	Altered mechanical properties and deformation capacity [13]
Microtubule Radiality	Prominent radial pattern nucleating from nucleus centroid (Radial Score ≈ 0.564) [13]	Loss of radial organization from nucleus [23]	Radial Score (RS) measurement relative to nucleus centroid [13]	Disrupted cell polarity and directional sensing [23]
Actin Organization	Normal cortical actin with fewer stress fibers [23]	Thicker, more numerous basal stress fibers [23]	Fluorescent phalloidin staining and quantification [23]	Enhanced contractility and force generation [59]
Overall Phenotype	Epithelial, cohesive growth [56]	Discohesive, invasive growth with single-file pattern [56]	Phase-contrast microscopy and invasion assays [23]	Associated with invasive capacity in lobular breast cancer [56]

Key Experimental Findings in Model Systems

In engineered MCF10A breast epithelial cells with complete CDH1 knockout (MCF10A CDH1-/-), the apical microtubule network lost the characteristic radial organization present in wild-type cells, accompanied by F-actin reorganization into thicker, more numerous stress fibers in the basal cellular region [23]. Despite these cytoskeletal alterations, E-cadherin loss alone proved insufficient to induce a complete EMT in this non-malignant background, with no upregulation of key mesenchymal markers like N-cadherin, vimentin, or fibronectin [23]. This suggests that additional molecular events are necessary for full malignant progression.

Validating these observations through a novel computational pipeline, researchers demonstrated that microtubules in cells expressing a deleterious E-cadherin variant (p.L13_L15del) associated with hereditary diffuse gastric cancer were significantly shorter, exhibited disperse orientations, and were more compactly distributed compared to their wild-type counterparts [13]. This structured quantification of cytoskeletal architecture provides a powerful proxy for identifying cells with disseminating potential based on structural organization rather than mere protein expression levels.

Methodological Framework: Experimental Protocols and Computational Analysis

Experimental Workflow for Cytoskeletal Analysis

Diagram Title: Cytoskeletal Analysis Workflow

Detailed Experimental Protocols

Cell Culture and Model Establishment

• Isogenic Cell Line Generation: Engineered CDH1 knockout in MCF10A non-malignant breast epithelial cells using CompoZr ZFN technology, creating MCF10A CDH1-/- with homozygous 4bp deletion in exon 11 [23]. Validate complete E-cadherin loss via western blot (anti-E-cadherin antibody Santa Cruz SC7870, 1:200 dilution) and immunofluorescence microscopy [23].
• Culture Conditions: Maintain MCF10A and isogenic derivatives in DMEM/F12 (1:1) supplemented with 5% horse serum, 10 μg/ml insulin, 20 ng/ml EGF, 100 ng/ml cholera toxin, and 500 ng/ml hydrocortisone at 37°C with 5% CO2 [23]. For low-calcium conditions (0.05 mM CaCl2) to dissociate cell-cell adhesions, use specialized keratinocyte growth media (KGM) [38].
• Pharmacological Manipulation: Microtubule disruption using nocodazole (33 μM) or colcemid (1 μg/ml); actin disruption with cytochalasin B (25 μM); PKC modulation with PMA (10 nM) or GF190203X (1 μM) [38].

Image Acquisition and Preprocessing Pipeline

• Immunofluorescence Staining: Fix cells with 4% paraformaldehyde, permeabilize with 0.2% Triton-X100, block with 10% FBS. Stain with primary antibodies against α-tubulin (microtubules), F-actin (fluorescent phalloidin), and nucleus (DAPI) [13] [23].
• High-Resolution Imaging: Acquire Z-stack images using confocal microscopy with consistent exposure settings across comparisons. Use 40× or higher magnification objectives for single-cell resolution [13].
• Computational Preprocessing:
  • Deconvolution: Remove noise and blur while improving contrast and resolution
  • Maximum Intensity Projection (MIP): Create 2D projections from Z-stacks
  • Gaussian Filtering: Smooth fluorescence signals for enhanced feature detection
  • Sato and Hessian Filtering: Highlight curvilinear structures and generate binary images
  • Skeletonization: Reduce microtubules to single-pixel width for morphological analysis [13]

Computational Feature Extraction Algorithms

Table 2: Key analytical parameters in cytoskeletal architecture quantification

Parameter Category	Specific Metrics	Computational Method	Biological Interpretation
Morphology	Fiber length (LiE), length variability, fractal dimension	Line Segment Features (LSFs) analysis	Structural complexity and polymerization dynamics [13]
Orientation	Orientational Order Parameter (OOP), angular distribution	Angular distribution (θi) of cytoskeletal fibers	Directional persistence and migration coordination [13]
Distribution	Number of lines (Nl), compactness (Nl/Ac)	Cytoskeleton Network Features (CNFs)	Spatial organization and mechanical properties [13]
Architecture	Radiality score, fiber-nucleus distance (Di)	Radial measurement from nucleus centroid	Cell polarization and intracellular organization [13] [23]
Connectivity	Bundling, parallelism, connectivity, complexity	Graph theory and network analysis	Structural integrity and force transmission efficiency [13]

Molecular Mechanisms: Signaling Pathways Connecting E-Cadherin to Cytoskeletal Dynamics

Integrated Molecular Pathway Map

Diagram Title: E-Cadherin Loss Cytoskeletal Signaling Network

Key Pathway Components and Regulatory Mechanisms

E-cadherin loss triggers profound cytoskeletal reorganization through multiple interconnected signaling pathways. The dissociation of catenin proteins from the adhesion complex following E-cadherin disruption represents the initial molecular event [56]. While β-catenin may translocate to the nucleus to modulate Wnt signaling, p120-catenin mislocalization induces Rho GTPase imbalance, characterized by RhoA/ROCK hyperactivation and concomitant Rac1/Cdc42 suppression [59] [56]. This Rho GTPase switch promotes actin reorganization through increased stress fiber formation and cellular contractility via ROCK-mediated phosphorylation of myosin light chain and LIM kinase [59].

Concurrently, microtubule networks undergo comprehensive reorganization through both Rho GTPase-dependent and independent mechanisms. Suppressed Rac1/Cdc42 signaling diminishes microtubule stabilization normally mediated through these pathways, while RhoA hyperactivation alters microtubule dynamics through its effector mDia1 [59]. The resulting microtubule destabilization is further amplified by dysregulation of microtubule-associated proteins (MAPs), including potential stathmin overexpression and Navigator protein dysregulation, ultimately producing the characteristic short, compact microtubule architecture observed in invasive E-cadherin mutant cells [13] [59]. This cytoskeletal rewiring collectively enables the transition to a discohesive, invasive phenotype characteristic of advanced carcinomas.

The Scientist's Toolkit: Essential Research Reagents and Solutions

Table 3: Key research reagents for investigating cytoskeletal changes in E-cadherin deficient models

Reagent Category	Specific Examples	Function/Application	Experimental Context
Cell Models	MCF10A CDH1-/- (ZFN-engineered knockout) [23]	Isogenic system for E-cadherin loss-of-function studies	Breast epithelial architecture and transformation [23]
Antibodies	Anti-E-cadherin (Santa Cruz SC7870) [23]	Validate E-cadherin expression and localization	Immunofluorescence, Western blot [23]
	Anti-α-tubulin [13]	Microtubule visualization	Cytoskeletal architecture analysis [13]
	Anti-phosphotyrosine (PY20) [38]	Detect tyrosine phosphorylation signaling	Adhesion complex signaling studies [38]
Chemical Modulators	Nocodazole (33 μM) [38]	Microtubule disruption	Test microtubule contribution to adhesion [38]
	Cytochalasin B (25 μM) [38]	Actin filament disruption	Examine actin cytoskeleton role in adhesion [38]
	PMA (10 nM) [38]	PKC activation	Investigate PKC signaling in adhesion regulation [38]
Computational Tools	Line Segment Feature (LSF) analysis [13]	Quantify microtubule morphology and orientation	Extract quantitative cytoskeletal metrics [13]
	Cytoskeleton Network Features (CNFs) [13]	Analyze network connectivity and complexity	Graph theory-based cytoskeletal assessment [13]
Software/Pipelines	Custom computational framework [13]	Comprehensive cytoskeletal architecture analysis	Integrate multiple parameters for invasive signature identification [13]

Discussion and Research Implications

The distinct cytoskeletal signature observed in E-cadherin deficient cells—characterized by shortened, compact microtubules with disorganized orientation and loss of radial architecture—provides a structural biomarker for invasive potential that transcends conventional molecular markers. This architectural remodeling results from sophisticated interplay between adhesion and cytoskeletal signaling networks, particularly through Rho GTPase imbalances and microtubule-associated protein dysregulation [13] [59] [23].

From a translational perspective, these cytoskeletal signatures offer promising avenues for diagnostic and therapeutic development. The computational pipeline described enables quantitative assessment of invasion potential based on structural organization rather than mere protein expression [13] [60]. This approach could enhance cancer diagnosis and prognostication, particularly in challenging cases such as invasive lobular breast cancer where traditional imaging and diagnostic criteria may be insufficient [56]. Furthermore, the identified vulnerabilities in cytoskeletal regulation present potential therapeutic targets, with microtubule-stabilizing agents or specific inhibitors of cytoskeletal regulators like PAKs, FAK, and MASTL representing promising candidates for restoring normal cellular architecture or impeding invasion [58].

Future research directions should prioritize expanding the validation of these cytoskeletal signatures across diverse cancer types, developing standardized analytical protocols for clinical translation, and exploring therapeutic interventions that specifically target the cytoskeletal remodeling processes driven by E-cadherin dysfunction. The integration of cytoskeletal architecture assessment into diagnostic workflows and drug development pipelines holds significant promise for advancing personalized cancer medicine and improving outcomes for patients with aggressive, invasive carcinomas.

The cytoskeleton is a dynamic, interconnected network essential for maintaining cellular architecture, mechanical integrity, and facilitating processes such as cell migration and division. In cancer, the dysregulation of cell-cell adhesion and the ensuing cytoskeletal reorganization are pivotal drivers of invasion and metastasis [13] [39]. This review provides a comparative analysis of cytoskeletal alterations in two distinct but related pathological contexts: Hereditary Diffuse Gastric Cancer (HDGC), primarily caused by germline mutations in the CDH1 gene encoding E-cadherin, and other cadherin-switching pathologies, most notably the E- to N-cadherin switch that occurs during Epithelial-to-Mesenchymal Transition (EMT) in sporadic cancers.

HDGC offers a genetically defined model to study the consequences of direct E-cadherin loss-of-function [61] [62]. In contrast, the cadherin switch in broader EMT involves not only the downregulation of E-cadherin but also the concurrent upregulation of N-cadherin and a profound reprogramming of the cellular transcriptome [39] [63]. By juxtaposing the cytoskeletal patterns in these contexts, this guide aims to delineate unique and shared vulnerabilities, thereby informing targeted therapeutic strategies.

Pathophysiological Background and Molecular Initiators

The initial molecular defects in HDGC and general EMT pathologies are distinct, setting the stage for divergent and convergent cytoskeletal remodeling.

Table 1: Molecular Initiators and Key Features in HDGC vs. General EMT

Feature	Hereditary Diffuse Gastric Cancer (HDGC)	General EMT and Cadherin-Switching Pathologies
Primary Genetic Cause	Germline CDH1 or CTNNA1 mutations [61] [62]	Somatic mutations, transcriptional repression (e.g., by Snail, Twist, ZEB1), promoter hypermethylation [39] [63]
Key Adhesion Alteration	Loss of E-cadherin function and expression [62] [64]	"Cadherin Switch": E-cadherin downregulation with concurrent N-cadherin upregulation [39]
Second Hit in HDGC	Somatic inactivation of wild-type allele via promoter hypermethylation or loss of heterozygosity [62]	Not Applicable
Defining Context	A specific, inherited cancer syndrome [61]	A common mechanism in carcinoma progression and metastasis [39] [63]

In HDGC, the biallelic inactivation of CDH1 leads to a complete loss of functional E-cadherin, a master regulator of adherens junctions [62]. This loss disrupts the link between the transmembrane adhesion complex and the actin cytoskeleton, initiating a cascade of intracellular signaling and structural changes [65]. In contrast, during EMT, the repression of E-cadherin is accompanied by the expression of N-cadherin. This cadherin switch alters the nature of cell-cell interactions, promoting increased motility and interaction with stromal cells [39]. The cytoplasmic domain of N-cadherin recruits a different set of binding partners, leading to distinct signaling outputs and cytoskeletal reorganization compared to the simple loss of E-cadherin seen in HDGC [39] [63].

Quantitative Comparison of Cytoskeletal and Topological Alterations

Advanced computational and imaging approaches have enabled the precise quantification of cytoskeletal and cellular topological features, revealing both shared and context-specific patterns of disorganization.

Cytoskeletal Architecture in E-cadherin Dysfunctional Models

A novel computational pipeline analyzing microtubule networks in cells with HDGC-associated E-cadherin disruption (p.L13_L15del mutant) revealed specific defects compared to wild-type cells [13].

Table 2: Quantitative Cytoskeletal Features in E-cadherin Mutant vs. Wild-Type Cells

Cytoskeletal Feature	Wild-Type E-cadherin Cells	E-cadherin Mutant (HDGC model)	Functional Implication
Microtubule Orientation (OOP)	Higher (0.475 in a representative cell) [13]	Significantly lower (e.g., 0.019, 0.139) [13]	Loss of directional alignment and organization
Microtubule Length (LiE)	Variable	Shorter fibers [13]	Compromised intracellular transport and cell polarity
Fiber Compactness (Nl/Ac)	Lower (e.g., 0.421 μm⁻²) [13]	Higher (e.g., 1.539-2.039 μm⁻²) [13]	More densely packed, disorganized cytoskeleton
Fiber Radiality (RS)	Can be high (e.g., 0.564) [13]	Lower radial distribution [13]	Disrupted nucleation from the cell and nuclear center

This analysis demonstrates that E-cadherin deficiency alone is sufficient to cause a significant breakdown in microtubule architecture, characterized by shorter, misoriented, and more densely packed fibers [13].

Topological and Morphological Alterations in Cell Assemblies

Beyond the internal cytoskeleton, the loss of E-cadherin function profoundly impacts cell-cell interactions and tissue topology. A quantitative imaging approach that constructs network diagrams from cell nuclei positions has been used to measure this disorganization [66].

Table 3: Topological Parameters in E-cadherin Dysfunctional Cell Networks

Topological Parameter	Wild-Type E-cadherin	E-cadherin Missense Mutants (e.g., A634V, R749W, P799R)	Interpretation
Mean Triplet Area	1526 μm² [66]	1979 - 2115 μm² [66]	Looser cell packing
Internuclear Distance	62.61 μm [66]	71.79 - 73.82 μm [66]	Weaker cell-cell adhesion
Length/Angle Distortion	Lower [66]	Significantly Higher [66]	More irregular, heterogeneous tissue architecture

These quantitative findings align with the functional role of E-cadherin in maintaining compact, ordered epithelial tissues. The increased distortion and heterogeneity in mutant networks are hallmarks of a more dynamic and invasive cellular phenotype [66].

Experimental Protocols for Cytoskeletal and Topological Analysis

To enable replication and standardization of research in this field, detailed methodologies for key experiments are outlined below.

Protocol 1: Computational Analysis of Cytoskeletal Architecture

This protocol is adapted from the pipeline developed to dissect microtubule architecture in cells with invasive potential [13].

• 1. Cell Culture and Staining: Culture cells of interest (e.g., stable lines expressing WT or mutant E-cadherin) on appropriate laminin-coated substrates to mimic the extracellular environment. Perform immunofluorescence staining for a cytoskeletal component (e.g., α-tubulin for microtubules) and a nuclear stain (e.g., DAPI) [13].
• 2. Image Acquisition: Acquire high-resolution fluorescence images using a confocal microscope. Capture multiple Z-stack images for each channel to account for the 3D structure of the cytoskeleton [13].
• 3. Image Preprocessing: Apply deconvolution to remove noise and blur. Use a maximum intensity projection (MIP) of the Z-stacks to generate 2D images for analysis. Process images with a Gaussian filter to smooth the signal and a Sato/Hessian filter to highlight curvilinear structures of fibers [13].
• 4. Segmentation and Skeletonization: Generate binary images from the processed fiber signals. Skeletonize the binary images to create a 1-pixel-wide representation of the cytoskeletal network [13].
• 5. Feature Extraction: Use custom algorithms (e.g., in Python or MATLAB) to extract two classes of features:
  • Line Segment Features (LSFs): Quantify fiber length, orientation, and bundling.
  • Cytoskeleton Network Features (CNFs): Analyze connectivity, complexity, and radiality relative to the nucleus centroid [13].
• 6. Data Analysis: Compare extracted features (OOP, length, compactness, radiality) between experimental groups (e.g., WT vs. mutant) using statistical tests.

The following workflow diagram illustrates this computational pipeline:

Protocol 2: Quantitative Topological Analysis of Cell Networks

This method quantifies the loss of tissue organization from 2D microscopy images, validated in models of E-cadherin dysfunction [66].

• 1. Cell Staining and Imaging: Seed cells at a defined density. Stain nuclei with DAPI and acquire widefield fluorescence microscopy images [66].
• 2. Nuclei Segmentation and Centroid Detection: Apply the Otsu method for denoising and the Moore-Neighbor tracing algorithm to identify individual nuclei. Compute the geometric centre (centroid) of each nucleus [66].
• 3. Network Generation: Input the list of nucleus centroids into a Delaunay triangulation algorithm. This algorithm connects neighboring points to form a mesh of triangles that accurately represents cell-cell interaction patterns. Remove outlier triangles with angles ≪ Ï€/2 or ≫ Ï€/2 to avoid artifacts [66].
• 4. Geometric Parameter Calculation: For each triangle in the mesh, calculate:
  • Edge length: The Euclidean distance between two nucleus centroids.
  • Triangle area: Using the standard geometric formula.
  • Length distortion (γk): Variance of the triangle's edge lengths compared to an equilateral triangle.
  • Angle distortion (φk): Variance of the triangle's angles compared to an equilateral triangle (all 60°) [66].
• 5. Statistical Comparison: Compare the distributions of area, edge length, and distortion metrics across different experimental conditions (e.g., WT vs. mutant E-cadherin) to quantify the degree of topological disorganization.

Signaling Pathways and Mechanobiological Dynamics

The cytoskeletal alterations in both HDGC and EMT are driven by dysregulated signaling pathways and mechanobiological feedback loops.

Signaling Pathways in E-cadherin Dysfunction and EMT

The loss of E-cadherin function disrupts multiple signaling hubs. In HDGC, the CDH1/CTNNA1 second hit leads to E-cadherin deficiency, which can dysregulate Wnt and Notch signaling pathways, facilitating progression from indolent to invasive lesions [62]. A central event in this process is the disruption of the E-cadherin/catenin complex, which compromises cell-cell adhesion and releases β-catenin, potentially activating proliferative genes [62] [39].

In EMT pathologies, a complex network of transcription factors (Snail, Twist, ZEB) drives the cadherin switch. The subsequent change in cadherin profile activates pro-invasive signaling pathways, including receptor tyrosine kinases (RTKs) and integrins, further promoting cytoskeletal remodeling and metastasis [39] [63].

The diagram below illustrates the key signaling and mechanistic differences between these two pathways:

Cortical Flow Dynamics in Adhesion Formation

Beyond transcription, E-cadherin adhesion directly regulates the actomyosin cortex. A biomimetic assay revealed that E-cadherin engagement downregulates the small GTPase RhoA at the contact site, leading to local depletion of myosin-2 and F-actin [65]. This creates a tension gradient from the contact rim (high tension) to the center (low tension), which drives centrifugal F-actin flows. These flows, in turn, transport E-cadherin and F-actin to the contact rim, building the mature adhesion structure that mechanically links the cortices of adjoining cells [65]. This mechanism illustrates how E-cadherin directly patterns the cytoskeleton through mechanochemical feedback.

The Scientist's Toolkit: Key Research Reagents and Solutions

Table 4: Essential Reagents for Studying Cytoskeleton in Cadherin Pathologies

Reagent / Solution	Function / Application	Key Details / Specific Examples
E-cadherin Mutant Models	Modeling HDGC-specific loss of function	HDGC-associated mutants (e.g., p.L13_L15del, A634V, R749W, P799R) in stable cell lines [13] [66] [64]
Laminin-coated Substrata	Mimics supportive ECM environment	Provides a physiologically relevant context for studying cell-ECM and cell-cell interactions [13]
Antibodies for IF	Visualizing cytoskeletal and junctional components	α-Tubulin (microtubules), Phalloidin (F-actin), E-cadherin, N-cadherin, β-catenin [13] [39] [64]
Proximity Ligation Assay (PLA)	Detecting protein-protein interactions	Validates pathogenicity of E-cadherin missense mutants by testing binding to p120, β-catenin, PIPKIγ [64]
Delaunay Triangulation Algorithm	Quantifying cellular topology from 2D images	Generates cell-based graphs for calculating area, edge length, and distortion metrics [66]
Computational Feature Extraction	Quantifying cytoskeletal architecture	Custom pipelines for OOP, fiber length, compactness, and radiality [13]

This comparative analysis reveals that while the direct loss of E-cadherin in HDGC and the cadherin switch in EMT both culminate in cytoskeletal disorganization and increased invasiveness, they originate from distinct molecular mechanisms and exhibit unique pathological features. HDGC models are characterized by a complete, genetically-driven loss of E-cadherin, leading to specific microtubule defects and multifocal signet ring cell lesions. In contrast, EMT pathologies involve a more complex reprogramming, where the E- to N-cadherin switch activates alternative signaling pathways that promote a robust mesenchymal and migratory cytoskeleton.

Understanding these nuanced differences is critical for the development of targeted therapies. For instance, strategies aimed at synthetic lethality in CDH1-deficient cells may be highly specific for HDGC, while interventions targeting the EMT transcription factors or N-cadherin function could have broader applicability in combating metastasis in sporadic cancers. Future research integrating advanced imaging, omics technologies, and 3D disease models will further refine our understanding of these cytoskeletal patterns, paving the way for precision medicine approaches in treating cadherin-dependent cancers.

The integration of in silico (computational) and in vitro (laboratory) methods has become a cornerstone of modern biomedical research, providing a powerful framework for validating scientific findings. This is particularly true in the study of complex biological processes like cell extrusion, a critical event in cancer progression where cells detach from an epithelial monolayer. Within this context, the validation of computational models against experimental data is paramount for establishing their predictive power and biological relevance. Regulatory agencies now consider evidence produced in silico for marketing authorization of new medical products, provided the models undergo rigorous credibility assessment [67]. This guide compares methodologies and outcomes when studying cytoskeletal alterations and extrusion behavior of wild-type versus mutant E-cadherin cells, a key system in hereditary diffuse gastric cancer (HDGC) research.

Experimental Protocols: A Side-by-Side Comparison

1In VitroExtrusion and Cytoskeletal Analysis Assays

In vitro experiments provide the foundational biological data against which computational predictions are measured. Key protocols include:

1. Basal Extrusion Assay: This experiment models the initial step of cancer cell invasion. An epithelial monolayer is established by culturing cells on a collagen matrix. Fluorescently labelled E-cadherin mutant cells are diluted amidst wild-type cells, mimicking the sporadic emergence of mutant cells in a healthy epithelium. Confocal microscopy in the xz-plane is then used to monitor and quantify the position of mutant cell nuclei relative to the wild-type monolayer, specifically measuring the rate of basal extrusion into the matrix [8].

2. Automated Cytoskeletal Architecture Analysis: This quantitative imaging pipeline characterizes the cytoskeletal reorganization associated with invasive potential. Cells stained for α-tubulin (a microtubule component) undergo high-resolution image acquisition. A sequence of computational filters (Gaussian, Sato, and Hessian) is applied to enhance curvilinear structures and generate binary images. These are then skeletonized for automatic extraction of specific Line Segment Features (LSFs) and Cytoskeleton Network Features (CNFs). Metrics include fiber orientation (Orientational Order Parameter - OOP), quantity, length, compactness, and radiality, creating a comprehensive profile of cytoskeletal architecture [13].

2In SilicoModeling and Simulation Approaches

Computational models offer a way to dissect the complex biophysical rules governing extrusion. Primary approaches include:

1. Phase-Field Modeling: This method is used to simulate the interaction between a single E-cadherin dysfunctional cell and its wild-type neighbors within a flat epithelial tissue positioned above an extracellular matrix (ECM). The model represents cell boundaries and the ECM as continuous fields. It incorporates parameters for cell-cell adhesion (absent in the mutant) and cell-ECM adhesion. The simulation outputs, such as extrusion distance and velocity, allow researchers to test the impact of modulating ECM attachment strength on the invasive potential of the mutant cell [8].

2. E-cadherin Clustering under Force (Brownian Dynamics): This mesoscale model investigates the formation of E-cadherin clusters at cell-cell junctions under mechanical force. It represents E-cadherin molecules as diffusing particles on parallel membranes. The model simulates transitions between molecular states (monomers, trans-dimers, cis-clusters) and their connection to the actomyosin cytoskeleton. The application of force (Factin) allows for the analysis of how cytoskeletal-generated tension influences cluster size and density, providing mechanistic insight into how adhesion is reinforced or disrupted [68].

3. Dissipative Particle Dynamics (DPD): Mentioned as a validation tool alongside phase-field models, DPD simulations track the movement and adhesion of coarse-grained particles representing cells. This technique is particularly useful for verifying that observed extrusion behaviors, such as the promotion of basal extrusion by increased ECM adhesion, are consistent across different modeling methodologies [8].

The workflow below illustrates how these experimental and computational approaches are integrated to validate findings in a closed loop.

Quantitative Data Comparison

The correlation between in silico predictions and in vitro observations is the benchmark for successful validation. The tables below summarize key quantitative findings from both approaches regarding extrusion behavior and cytoskeletal alterations.

Table 1: Comparative Quantitative Data on Extrusion Behavior and Cytoskeletal Architecture

Parameter	In Vitro Observation	In Silico Prediction	Correlation & Context
Basal Extrusion Rate	R749W mutant: 44.91% basal extrusion [8]	Phase-field model confirms loss of E-cadherin enables basal extrusion; efficiency increases with higher cell-ECM adhesion [8].	Strong qualitative and quantitative agreement. Model identifies adhesion strength as a key tunable parameter.
Microtubule Orientation (OOP)	Mutant E-cadherin cells show significantly lower OOP, indicating disorganized fibers [13].	Not directly predicted in the provided models. Cytoskeletal analysis is an in vitro validation step.	In vitro data provides a phenotypic signature (disorganized cytoskeleton) for the mutant cells modeled in silico.
Actomyosin Force on E-cadherin	Force reinforces cell-cell adhesions; differences in cluster size observed apically vs. laterally [33].	Brownian dynamics model predicts low force (<10 pN): many small clusters.Higher force: fewer, larger clusters [68].	Strong correlation. Model provides a mechanistic, force-dependent explanation for experimental observations.

Table 2: Comparison of Methodological Capabilities and Limitations

Aspect	In Vitro Experiments	In Silico Models
Primary Function	Generate empirical biological data; "ground truth."	Formulate and test biophysical mechanisms; generate hypotheses.
Key Readouts	Direct quantification of extrusion rates; high-resolution imaging of cytoskeletal and protein localization.	Prediction of cell trajectories, force distributions, and the effect of modulating parameters like adhesion strength.
Throughput & Cost	Lower throughput; higher cost per data point due to reagents and labor.	High throughput once developed; low marginal cost for testing new parameters.
Parameter Control	Control over biological variables (e.g., genotype, matrix) but with inherent biological noise.	Precise and independent control over specific parameters (e.g., adhesion strength, force).
Invasiveness	Can be invasive (e.g., fixation for imaging).	Entirely non-invasive.
Major Limitation	Difficulty in isolating the contribution of single physical parameters in a complex system.	Dependent on the accuracy of the underlying assumptions and model abstraction; requires validation.

Integrated Signaling and Workflow in E-cadherin Dysfunction

The following diagram synthesizes the core mechanisms linking E-cadherin dysfunction to cytoskeletal remodeling and basal extrusion, as revealed by the combined in vitro and in silico studies. This pathway highlights the critical nodes that can be targeted or measured in validation experiments.

The Scientist's Toolkit: Essential Research Reagents and Materials

Successful execution of the described validation pipeline requires a suite of specific reagents and computational tools. The following table details the key components.

Table 3: Essential Reagents and Tools for Extrusion and Cytoskeletal Research

Item	Function/Description	Application in Context
Collagen Matrix	A biomimetic 3D extracellular matrix (ECM) providing a supportive scaffold for cell growth.	Used as the substrate in the in vitro basal extrusion assay to model the stromal environment [8].
E-cadherin Mutant Cell Lines	Engineered cells expressing HDGC-associated E-cadherin variants (e.g., A634V, R749W, V832M).	Essential for creating disease models to study the functional impact of specific mutations on adhesion and invasion [8].
Anti-α-Tubulin Antibody	A primary antibody for immunofluorescence staining of microtubule networks.	Enables visualization and quantification of the cytoskeletal architecture in the computational pipeline [13].
Fluorescent Cell Dye	A lipophilic or membrane-permeable dye (e.g., CM-Dil) for long-term cell labelling.	Used to tag E-cadherin mutant cells, allowing them to be tracked relative to wild-type neighbors in co-culture extrusion assays [8].
Phase-Field Modeling Software	Custom or commercial software (e.g., based on FEniCS, COMSOL) for solving phase-field equations.	Platform for developing and running in silico simulations of epithelial-ECM interactions and cell extrusion [8].
Image Analysis Pipeline (Sato/Hessian Filters)	A sequence of image processing filters implemented in platforms like Python or MATLAB.	Critical for automated segmentation and skeletonization of cytoskeletal fibers from fluorescence images [13].
SALSA (ScAffoLd SimulAtor)	A programmable hybrid continuous-discrete cellular automaton for 3D cell culture simulation.	Can be extended to model drug treatments and cell-ECM interactions in complex 3D microenvironments [69].

The cytoskeleton, a dynamic network of intracellular filaments, is fundamental to cell structure, division, and motility. In cancer research, its profound reorganization is increasingly recognized not merely as a consequence but as a driver of invasive capacity and metastatic risk. The architectural remodeling of the actin cytoskeleton, microtubules, and intermediate filaments enables carcinoma cells to detach from primary tumors, invade surrounding tissues, and disseminate. This review objectively compares the biomarker potential of specific cytoskeletal features, framing the analysis within the context of E-cadherin dysfunction, a well-established initiator of invasive phenotypes in cancers such as Hereditary Diffuse Gastric Cancer (HDGC) and invasive lobular breast cancer (ILC) [8] [12] [70]. For researchers and drug development professionals, quantifying these cytoskeletal alterations offers a promising path to prognostic tools and novel therapeutic targets. This guide compares the experimental data supporting various cytoskeletal proxies, details the methodologies for their assessment, and provides a toolkit for their investigation.

Comparative Analysis of Cytoskeletal Biomarker Candidates

The following sections and tables provide a structured comparison of key cytoskeletal features with demonstrated links to cancer cell invasion and metastasis.

Table 1: Core Cytoskeletal Filaments and Their Biomarker Potential in Cancer

Cytoskeletal Component	Key Alteration in Invasion/EMT	Associated Functional Outcome	Experimental Evidence
Actin Filaments	Reorganization from cortical bundles to F-actin stress fibers; formation of lamellipodia and filopodia [71].	Enhanced cell migration, invasion, and ECM degradation [71].	In vitro migration/invasion assays (e.g., Transwell); phase-field modeling of extrusion [8] [72].
Intermediate Filaments	Switch from keratins to vimentin [71].	Loss of epithelial integrity, acquisition of mesenchymal phenotype; increased cell motility [72] [71].	Immunofluorescence staining used as a standard mesenchymal marker in EMT studies [72].
Microtubules	Reorganization for cell polarization and front-rear polarity during migration [71].	Directional cell migration, intracellular trafficking of vesicles and organelles [71].	Analysis of cell polarization and migration pathways in cultured cells.

Table 2: Quantitative Data from Key Studies on Cytoskeleton-Associated Invasion

Study Focus / Experimental System	Key Quantitative Finding	Implication for Metastatic Risk
E-cadherin Mutants & Basal Extrusion [8]	18.6% - 44.9% of E-cadherin mutant cells (vs. wild-type) underwent basal extrusion when surrounded by normal cells, depending on the mutated domain.	Basal extrusion into the stroma is a direct measure of initial invasive behavior triggered by E-cadherin loss.
Computational Modeling of ECM Attachment [8]	Phase-field models demonstrated that increased cell-ECM adhesion significantly raised basal extrusion efficiency and velocity.	Aberrant cell-ECM interplay, a cytoskeleton-dependent process, is a key determinant of invasion.
Afadin Loss in Breast Cancer [12]	Afadin loss led to immature adherens junctions, a noncohesive phenotype, and anoikis resistance, resulting in single-cell invasion and lung metastasis in xenografts.	Disruption of the E-cadherin-actin linkage via Afadin is a alternative mechanism to E-cadherin mutation that promotes metastasis.

Detailed Experimental Protocols for Assessing Cytoskeletal Dysfunction

To ensure reproducibility and objective comparison, this section outlines detailed methodologies for key experiments cited in this field.

In Vitro Monolayer Extrusion Assay for E-cadherin Dysfunctional Cells

This protocol, adapted from a study on HDGC, tests the intrinsic invasive potential of cells upon loss of cell-cell adhesion [8].

• Primary Objective: To quantify the basal extrusion capacity of E-cadherin mutant cells in a wild-type epithelial context.
• Materials:
  • Wild-type epithelial cells (e.g., MCF-10A for breast, MKN-28 for gastric).
  • E-cadherin mutant isogenic cell lines (e.g., expressing A634V, R749W, or V832M CDH1 mutants).
  • Fluorescent cell tracker dye (e.g., CellTracker Red) for mutant cell labeling.
  • Collagen I matrix for 3D substrate.
  • Confocal microscopy setup for xz-sectioning.
• Methodology:
  • Cell Preparation: Label E-cadherin mutant cells with a fluorescent dye. Mix these labeled cells with unlabeled wild-type cells at a very low ratio (e.g., 1:100).
  • Monolayer Formation: Plate the mixed cell population on a polymerized collagen I matrix to form a confluent monolayer.
  • Incubation and Fixation: Culture cells for 24-48 hours to allow for monolayer stabilization and extrusion events. Fix cells and stain nuclei with DAPI.
  • Imaging and Quantification: Acquire high-resolution confocal xz-sections of the entire monolayer. For each fluorescently labeled mutant cell, determine its position relative to the monolayer: apical, within, or basally extruded.
  • Data Analysis: Calculate the percentage of basally extruded mutant cells versus wild-type controls. Statistical significance is typically determined using a student's t-test.

Phase-Field Computational Modeling of Cell Extrusion

This computational approach complements wet-lab experiments by modeling the biophysical interactions during extrusion [8].

• Primary Objective: To simulate and quantify the impact of cell-ECM adhesion strength on the basal extrusion of E-cadherin-deficient cells.
• Materials:
  • Phase-field modeling software or custom code (e.g., based on finite element methods).
  • High-performance computing resources.
• Methodology:
  • Model Setup: Construct a 3D phase-field model of a flat epithelial tissue (e.g., 16 cells in a hexagonal lattice) positioned above an ECM layer.
  • Parameter Definition: Define parameters for cell properties, including cell-cell adhesion (set to low for the "mutant" cell) and cell-ECM adhesion (varied for the mutant cell).
  • Simulation Execution: Run the simulation over a defined time course, allowing the mutant cell to interact with neighboring wild-type cells and the ECM.
  • Output Measurement: Track the position of the mutant cell over time. Key metrics include extrusion distance and velocity.
  • Sensitivity Analysis: Run multiple simulations while systematically varying the mutant cell's adhesion strength to the ECM to establish a quantitative relationship.

Functional Assessment of Actin-Binding Proteins via Reconstitution

This protocol, derived from Afadin research, tests how specific protein domains regulate cytoskeletal linkage and metastasis [12].

• Primary Objective: To identify the critical domains of cytoskeletal scaffolding proteins (e.g., Afadin) required for mature junction formation and metastasis suppression.
• Materials:
  • Afadin-knockout (KO) breast cancer cells (e.g., derived from MCF7).
  • Expression vectors for full-length Afadin and truncation mutants (e.g., lacking the Coiled-Coil (CC) domain or the F-actin binding (FAB) domain).
  • Immunofluorescence (IF) antibodies against E-cadherin, F-actin (e.g., phalloidin), and Afadin.
  • Mouse xenograft models for in vivo validation.
• Methodology:
  • Reconstitution: Stably transfect Afadin-KO cells with vectors for full-length or truncated Afadin.
  • In Vitro Phenotyping: Perform IF staining for E-cadherin and F-actin. Analyze the morphology of adherens junctions (mature linear vs. immature punctate) and the organization of the cortical actin belt using confocal microscopy.
  • Functional Assays: Subject the reconstituted cells to assays for cohesion (e.g., colony dispersion) and anoikis resistance.
  • In Vivo Validation: Inject the cell lines into immunocompromised mice (e.g., NSG). Monitor for primary tumor growth and, crucially, for the development of metastatic lesions in lungs and peritoneum via histopathology.

Signaling Pathways and Molecular Mechanisms

The dysregulation of the cytoskeleton in invasive cancers is orchestrated by a network of signaling pathways and molecular interactions, often initiated by the loss of E-cadherin function.

Diagram 1: Signaling from E-cadherin dysfunction to cytoskeletal reorganization and invasion. Pathways are derived from analysis of multiple studies [8] [12] [70].

The Scientist's Toolkit: Essential Research Reagents and Models

Successfully investigating cytoskeletal biomarkers requires a carefully selected toolkit of reagents and experimental models.

Table 3: Research Reagent Solutions for Cytoskeletal and Invasion Research

Reagent / Model	Specific Example	Function/Application in Research
Isogenic E-cadherin Mutant Cell Lines	A634V (extracellular), R749W (juxtamembrane), V832M (intracellular) [8].	To study domain-specific effects of E-cadherin dysfunction on cell adhesion and cytoskeletal organization in a controlled genetic background.
Phase-Field & Vertex Mathematical Models	Custom computational models simulating epithelium-ECM interaction [8].	To quantitatively dissect the biophysical contribution of parameters like cell-ECM adhesion strength to extrusion and invasion, independent of complex biochemical signaling.
3D Organoid Co-culture Models	Primary patient-derived breast cancer organoids [12].	To study invasion (e.g., lobular-type single-cell invasion) in a physiologically relevant context that preserves tumor architecture.
Key Antibodies for Immunofluorescence	Anti-E-cadherin, Anti-l-Afadin, Phalloidin (F-actin), Anti-vimentin [12] [71].	To visualize and quantify the distribution and organization of key cytoskeletal and adhesion proteins.
In Vivo Metastasis Models	Mouse orthotopic xenografts (cell lines or PDX) [12] [72].	The ultimate functional validation tool to assess the metastatic potential of cytoskeleton-altered cells and track dissemination to specific organs (e.g., lungs, peritoneum).

The systematic comparison of experimental data confirms that cytoskeletal features are robust proxies for invasive capacity and metastatic risk. Quantifiable phenomena such as basal extrusion efficiency, the molecular switch in intermediate filaments, and the reorganization of the actin cortex into stress fibers provide a measurable readout of internal cellular disruption, often rooted in E-cadherin dysfunction. The integration of innovative tools—from isogenic cell lines and 3D organoids to biophysically rigorous computational models—provides a powerful arsenal for deconvoluting the complex relationship between cytoskeletal architecture and cancer aggression. For drug developers, these cytoskeletal targets and associated pathways offer promising avenues for therapeutic intervention aimed at curbing metastasis, the principal cause of cancer mortality.

Conclusion

The integration of foundational biology, advanced computational methods, and rigorous validation reveals that E-cadherin dysfunction initiates a precise and quantifiable reorganization of the cytoskeleton, which is a critical driver of invasive cell behavior. Key takeaways include the identification of unique microtubule signatures—shorter fibers with altered orientation and compactness—as hallmarks of E-cadherin loss, and the critical role of cell-ECM attachment in facilitating basal extrusion. Future research must focus on translating these cytoskeletal biomarkers into clinical tools for early cancer detection and developing therapeutic strategies that target the cytoskeletal remodeling process to inhibit metastasis, ultimately offering new avenues for intervention in HDGC and other invasive carcinomas.

References

• 1. E-Cadherin/β-Catenin Complex and the Epithelial Barrier - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC3191826/]
• 2. Cadherin-Mediated Cell-Cell Adhesion and the Microtubule ... [https://www.ncbi.nlm.nih.gov/books/NBK6079/]
• 3. WAVE2 Protein Complex Coupled to Membrane and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3270453/]
• 4. Deconstructing the Cadherin-Catenin-Actin Complex - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC3368712/]
• 5. Re-solving the Cadherin-Catenin-Actin Conundrum - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC3368706/]
• 6. The E-cadherin-catenin complex in tumour metastasis [https://pubmed.ncbi.nlm.nih.gov/10959047/]
• 7. The Structure of the β-Catenin/E-Cadherin Complex and ... [https://www.sciencedirect.com/science/article/pii/S0092867401003300]
• 8. The ECM and tissue architecture are major determinants of ... [https://www.nature.com/articles/s42003-023-05482-x]
• 9. Dynamics of E-cadherin and catenin complexes γ ... [https://www.sciencedirect.com/science/article/pii/S0085253815463690]
• 10. The feasible role of soluble E‑cadherin in ... [https://pubmed.ncbi.nlm.nih.gov/40182609/]
• 11. E-cadherin loss alters cytoskeletal organization and adhesion ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4131020/]
• 12. Afadin loss induces breast cancer metastasis through ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11985701/]
• 13. A novel computational approach to dissect the cytoskeletal ... [https://www.nature.com/articles/s41598-024-82538-w]
• 14. Loss of E-cadherin Activates EGFR-MEK/ERK Signaling ... [https://cgp.iiarjournals.org/content/22/2/271]
• 15. E-cadherin and beta-catenin in malignant transformation of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11223640/]
• 16. A multicellular star-shaped actin network underpins epithelial ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12227619/]
• 17. Role of the cytoskeleton in cellular reprogramming [https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2025.1538806/full]
• 18. Microtubule architecture connects AMOT stability to YAP ... [https://www.nature.com/articles/s41556-025-01773-z]
• 19. Microtubule-Targeting Agents: Advances in Tubulin ... [https://www.mdpi.com/1422-0067/26/15/7652]
• 20. Discovery of novel microtubule destabilizing agents via ... [https://www.sciencedirect.com/science/article/abs/pii/S0169260725004146]
• 21. how polarity and the cytoskeleton orchestrate asymmetric cell ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12162993/]
• 22. Transcription Regulation of E-Cadherin by Zinc Finger E-Box ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4147210/]
• 23. E-cadherin loss alters cytoskeletal organization and adhesion ... [https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-552]
• 24. Immediate and Delayed Effects of E-Cadherin Inhibition on ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC1265771/]
• 25. Optimization of 3D Immunofluorescence Analysis and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9856541/]
• 26. Quantitative three-dimensional evaluation of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5330556/]
• 27. Optimizing immunofluorescence with high-dynamic-range ... [https://www.nature.com/articles/s41598-024-65187-x]
• 28. Immunofluorescence Tomography: High-resolution 3-D ... [https://www.nature.com/articles/s41598-018-38232-9]
• 29. E-cadherin mutations and cell motility: A genotype– ... [https://www.sciencedirect.com/science/article/abs/pii/S0014482709000901]
• 30. Morphology Based Method - an overview [https://www.sciencedirect.com/topics/computer-science/morphology-based-method]
• 31. A novel computational approach to dissect the cytoskeletal ... [https://pubmed.ncbi.nlm.nih.gov/39948135/]
• 32. Effect of wild-type and mutant E-cadherin on cell ... [https://pubmed.ncbi.nlm.nih.gov/15138368/]
• 33. Active contractility at E-cadherin junctions and its ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4353245/]
• 34. Morphological features of single cells enable accurate automated classification of cancer from non-cancer cell lines | Scientific Reports [https://www.nature.com/articles/s41598-021-03813-8]
• 35. Diffusion model predicts the geometry of actin cytoskeleton from cell morphology | PLOS Computational Biology [https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1012312]
• 36. The ECM and tissue architecture are major determinants of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10632478/]
• 37. Regulation of E-cadherin localization by microtubule ... [https://www.oncotarget.com/article/23798/text/]
• 38. Microtubule Disruption in Keratinocytes Induces Cell- ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC55644/]
• 39. The E-Cadherin and N-Cadherin Switch in Epithelial-to- ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6830116/]
• 40. Integration of Cadherin Adhesion and Cytoskeleton at ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5411698/]
• 41. Shared and Context-Specific Mechanisms of EMT and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12524752/]
• 42. Spatial integration of E-cadherin adhesion, signalling and ... [https://www.sciencedirect.com/science/article/abs/pii/S095506741630117X]
• 43. TMBIM1 promotes epithelial mesenchymal transition by ... [https://www.nature.com/articles/s41598-025-01699-4]
• 44. Integrating E-cadherin expression levels with TNM staging for ... [https://bmccancer.biomedcentral.com/articles/10.1186/s12885-025-13539-9]
• 45. Modeling the dynamics of EMT reveals genes associated ... [https://www.nature.com/articles/s41540-025-00512-2]
• 46. Epithelial-mesenchymal transition orchestrates tumor ... [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-025-06422-5]
• 47. BrainTract: segmentation of white matter fiber tractography ... [https://www.sciencedirect.com/science/article/abs/pii/S0306452225007316]
• 48. Fully Automated Segmentation of Fiber Bundles in ... [https://arxiv.org/html/2508.12942v1]
• 49. E-cadherin in Contact Inhibition and Cancer - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC6119098/]
• 50. The Role of Extracellular Matrix Stiffness in Regulating ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6382458/]
• 51. The Cytoskeleton Regulates Cell Attachment Strength - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC4572469/]
• 52. Cell–3D Matrix Interactions: Recent Advances and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9464680/]
• 53. Role of E-cadherin in epithelial barrier dysfunction [https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1506636/full]
• 54. Rebalancing of actomyosin contractility enables mammary ... [https://www.nature.com/articles/s41467-019-11716-6]
• 55. Epithelial guardians against cancer: integrating cell ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12511482/]
• 56. E-Cadherin-Mediated Cell-Cell Adhesion and Invasive ... [https://pubmed.ncbi.nlm.nih.gov/39821030/]
• 57. E-cadherin re-expression: Its potential in combating TRAIL ... [https://www.sciencedirect.com/science/article/pii/S0378111924001744]
• 58. Cytoskeletal dynamics in breast cancer [https://www.sciencedirect.com/science/article/pii/S2667005425001188]
• 59. The emerging role of microtubules in invasion plasticity - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC9969133/]
• 60. Unraveling the cytoskeletal of cancer architecture ... - Scholar cells [https://scholar.tecnico.ulisboa.pt/records/JIsLUh5WzbzOJed2hC59VGuf27XrHk5e-d_J]
• 61. Current advances and challenges in Managing Hereditary ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11462652/]
• 62. Current advances in understanding the molecular profile of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9985294/]
• 63. E-cadherin: A potential biomarker in cancer and ... [https://www.sciencedirect.com/science/article/abs/pii/S0304419X25002082]
• 64. The importance of E-cadherin binding partners to evaluate ... [https://www.nature.com/articles/ejhg2012159]
• 65. Article Adhesion-induced cortical flows pattern E-cadherin- ... [https://www.sciencedirect.com/science/article/pii/S096098222301655X]
• 66. Quantification of topological features in cell meshes to ... [https://www.nature.com/articles/srep25101]
• 67. In silico trials: Verification, validation and uncertainty ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7883933/]
• 68. Computational model of E-cadherin clustering under force [https://pmc.ncbi.nlm.nih.gov/articles/PMC8633835/]
• 69. Development and validation of an in-silico tool for the study ... [https://www.sciencedirect.com/science/article/abs/pii/S0010482521000056]
• 70. Dual role of E-cadherin in cancer cells - PMC - PubMed Central [https://pmc.ncbi.nlm.nih.gov/articles/PMC9621038/]
• 71. Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition [https://www.mdpi.com/2072-6694/13/8/1882]
• 72. Epithelial-to-mesenchymal transition (EMT) and cancer ... [https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-025-02338-2]